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ABSTRACT 
 
Autism is a behaviorally defined neurodevelopmental disorder characterized by 
qualitative impairments in social interaction, communication, and aberrant repetitive 
behaviors. Behavioral phenotyping in laboratory animals to simulate core symptomology 
has been a large research focus with the aim to not only elucidate the behavioral basis and 
neural underpinnings of the disorder, but also study potential remedial treatments. The 
present thesis evaluated the validity of the valproic acid (VPA) rat model of autism by 
examining perturbations in the neurodevelopmental trajectories – behavioral and 
neurobiological – of juvenile and adult rats prenatally exposed to VPA, as well as the 
therapeutic effects of early tactile stimulation on the synergistic brain-behavior 
relationship. Behavioral and neuroanatomical findings confirmed the face, construct, and 
predictive validity of the VPA rat model, given the ethological, etiological, and 
therapeutic similarities to facets of human autism; thus, reinforcing the VPA model as a 
viable model for the study of autism in rats.  
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CHAPTER 1 
General Introduction 
1.1. Autism Spectrum Disorders (ASD) 
1.1.1. Definition and Prevalence  
 Leo Kanner introduced the diagnostic concept of autism in 1943, based on his 
original case series of 11 children exhibiting severe deficits in sociability, communicative 
skills, and restricted and repetitive behaviors and/or interests. Kanner described autism as 
the child’s innate inability “to relate themselves in an ordinary way to people and 
situations from the beginning of life” and “to form the usual, biologically provided 
affective contact with people,” establishing the first clinical description of the 
pathognomonic disorder (Kanner, 1943). Owing to the heightened awareness over the 
past two centuries, the diagnostic criteria and clinical phenotype of autism has 
significantly shifted; originally being defined as ‘early-onset schizophrenia,’ then 
‘infantile autism,’ and later renamed ‘autism disorder’ (Eisenberg & Kanner, 1956; 
Weintraub, 2011). It has only been in the past few decades that the common name autism 
has incorporated a wide repertoire of symptomology and related disorders, given the 
tremendous heterogeneity in the genotype-phenotype relationship. That is, the 5th edition 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) has termed 
autism spectrum disorders (ASD) as the single diagnostic dimension to characterize 
classic autistic disorder, Asperger’s disorder, and pervasive developmental disorder not 
otherwise specified (PDD) (American Psychiatric Association, 2013). Within this 
diagnostic dimension, primarily two domains of symptoms define ASD: social-
communicative deficits, and restricted and repetitive interests and/or behaviors (Table 
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1.1). Symptom severity within these domains vary from mild to severe, including 
complete absence of social functioning and fixated rituals and/or repetitive motor 
behaviors to subtle dysfunctions in social interactions, verbal and nonverbal 
communication, and motor stereotypies (Schneider & Przewlocki, 2011). Despite the 
detailed analysis of the neurobehavioral derangements and the identification of possible 
diagnostic biomarkers, the etiology of autism still remains elusive.  
As postulated by Kanner in 1943, ASD forms “a ‘unique syndrome’, not 
heretofore reported, which seems to be rare enough, yet is probably more frequent than is 
indicated by the paucity of observed cases” (Kanner, 1943). Since then, Kanner’s 
prediction has been fulfilled. In fact, since the first epidemiological studies conducted in 
the late 1960s, the global prevalence of ASD has increased twenty to thirtyfold. More 
specifically, the prevalence of ASD is progressively on the rise, currently affecting 1 in 
68 children, with a 5 times greater likelihood of occurrence in the male population 
(Centers for Disease Control and Prevention, 2014). Interestingly, a recent study on 
parent-reported ASD by the National Center for Health Statistics identified a prevalence 
estimate closer to 1 in 50 children (Blumberg et al., 2013). In part to the broadened 
diagnostic criteria, service availability, and increased awareness for ASD, a reported 29% 
increase in the prevalence of ASD was observed between 2008 and 2010, and 123% 
increase between the 2002 and 2010 in the United States (Centers for Disease Control 
and Prevention, 2014). Despite the extensive clinical research on defined ASD 
populations, these prevalence estimates cannot be taken as absolute. The influence of 
extrinsic factors such as geographic area, race or ethnicity, socioeconomic disparities, and 
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level of intellectual ability on ASD prevalence ought to also be explored, in order to 
better understand the etiological mechanisms underlying the origin of ASD. 
 
1.1.2. Behavioral Characterization 
 As purported by the DSM-V, ASD is a behaviorally defined disorder with early 
childhood onset. Characterized principally by impairments in social interaction, 
communication, and restricted, stereotypic patterns of behaviors and interests, the 
behavioral spectrum for ASD is heterogeneous in its presentation, ranging from mild to 
severe symptomology (American Psychiatric Association, 2013). For instance, clinical 
patterns in low-functioning children may present a complete absence of social interest 
and spoken language, whereas those with high-functioning ASD possess a milder 
symptom profile (Geschwind & Levitt, 2007). As such, it is evident that the severity of 
impairment varies along the spectrum and is individual-specific, where no two 
individuals with ASD possess the same behavioral profile (Lord, Cook, Leventhal, & 
Amaral, 2000). Generally speaking, deficits in social interaction and social 
communication may include impaired peer initiation, engagement, and response; poor 
pragmatic and social use of verbal and nonverbal communication; lack of theory of mind 
(inability to ascribe mental states to others); and difficulties in developing and 
maintaining social relationships. Restricted and repetitive behaviors and/or interests, on 
the other hand, may include atypical or pedantic speech; idiosyncratic language; 
stereotyped hand and whole body movements; preoccupations with objects and topics; 
preference for sameness; and complex routines or rituals, which are associated with 
distress when they cannot be fulfilled (Table 1.1; American Psychiatric Associaton, 2013; 
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Ventola, Oosting, Anderson, & Pelphrey, 2013; Baron-Cohen, Leslie, & Frith, 1985).  
Table 1.1. Diagnostic criteria for ASD (American Psychiatric Association, 2013). 
Diagnostic Criteria for Autism Spectrum Disorder: 
A. Persistent deficits in social interaction and social communication across various 
contexts, as manifested by 3 of the following symptoms: 
1. Deficits in social-emotional reciprocity; including abnormal social approach, 
failure to initiate and respond to social interaction, inability to engage in normal 
back-and-forth conversation, and reduced sharing of affect, interests, and 
emotions. 
2. Deficits in nonverbal communicative behaviors used in social interaction; 
including abnormal eye contact and body language, lack of facial expressions 
and/or gestures, inability to integrate verbal and nonverbal communication 
during social interaction, and deficits in the use and understanding of nonverbal 
communication. 
3. Deficits in the development, maintenance, and comprehension of relationships 
(appropriate to developmental level and relationships beyond those with 
caregivers); including absence of interest in peers, difficulties adjusting behaviors 
to suit social contexts, and difficulties making friends.  
B. Restrictive, repetitive patterns of behavior or interests, as manifested by 2 of the 
following: 
1. Stereotyped or repetitive motor movements, speech, or use of objects; including 
idiosyncratic phrases, motor stereotypies, and echolalia. 
2. Excessive resistance to change, adherence to routines, and ritualized patterns of 
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verbal and nonverbal behavior; including difficulties with transitions, insistence 
on sameness, and motoric rituals. 
3. Highly fixated interests that are abnormal in intensity; including perseverative 
interests and preoccupation with unusual objects.  
4. Hyper- or hypo-reactivity to sensory input and/or abnormal interest in sensory 
features of the environment; including indifference to pain/cold/heat, excessive 
touching and smelling of objects, fascination with moving objects and lights, and 
adverse responses to certain sounds. 
C. Symptoms are present in early childhood, but absolute manifestation of 
symptoms may not emerge until social demands exceed limited capacities. 
D. Together, symptoms result in clinically significant impairments in social, 
occupational, and everyday functioning. 
E. Disturbances cannot be better explained by intellectual disability (i.e. intellectual 
developmental disorder) or global developmental delay. 
 
Additionally, a range of comorbid symptoms may also be exhibited, including 
hypersensitivity, abnormal pain reactivity, self injury, seizures, reduced joint attention, 
socially inappropriate behaviors, mental retardation, anxiety, and sleep disturbances 
(Sandman, 1990; Volkmar & Nelson, 1990; Bågenholm & Gillberg, 1991; Rapin, 1991; 
Realmuto & Ruble, 1999; Muris, Steerneman, Merckelbach, Holdrinet, & Meesters, 
1998; Kim, Szatmari, Bryson, Streiner, & Wilson, 2000; Militerni et al., 2000; Dawson et 
al., 2004; Liu, Hubbard, Fabes, & Adam, 2006; Baron-Cohen, Ashwin, Ashwin, 
Tavassoli, & Chakrabarti, 2009; Schneider & Przewlocki, 2011). Intellectual capabilities 
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also appear to be compromised in ASD, where approximately half of individuals with 
ASD display intellectual disability and less than one in five display moderate to severe 
intellectual disability (as measured by IQ) (Charman et al., 2011).  
 
1.1.3. Brain Abnormalities and Pathology 
 Given the multifaceted nature of ASD symptomology, it has been difficult to 
delineate a single unified neurological mechanism that may underlie the core features of 
ASD. Although an abundance of pathological studies – aimed at linking changes in brain 
structure and cellularity with atypical behavior – have emerged, findings are inconsistent 
with regard to the location and the alterations in the neural systems involved. The scope 
of this chapter is not to examine all findings contributing to the pathogenesis of ASD, but 
rather focus on two brain regions consistently implicated in ASD research and of the 
studies presented in this thesis: the prefrontal cortex (PFC) and the amygdala. 
 
1.1.3.1. Prefrontal Cortex (PFC) 
 The PFC constitutes the highest level of cortical hierarchy with regard to the 
representation and execution of actions. Memory, planning, social cognition, and 
executive functioning, all encompass the wide repertoire of higher-order cognitive, 
social, language, and emotional processes regulated by the PFC (Fuster, 2001; Stuss & 
Knight, 2002; Kolb & Whishaw, 2009). Given that many of these PFC-dependent 
functions are disrupted in ASD, it is likely that alterations in the neural circuitry underlie 
these impairments. That is, abnormal functioning within the PFC and/or diminished 
functional connectivity between the PFC and other brain areas may underlie the deficits 
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in sociality, attention, communication, multi-tasking, and stereotypic behaviors 
characteristic of ASD (Courchesne & Pierce, 2005; Rinaldi, Perrodin, & Markram, 2008). 
In the present thesis, two PFC areas are of particular interest: the medial prefrontal cortex 
(mPFC) and orbital prefrontal cortex (OFC). Well connected with the brainstem and 
limbic formations, both the mPFC and OFC play a major role in emotion, social 
processes, and the control of basic drives (Fuster, 2001) – all of which are thought to be 
implicated in ASD.  
 Located medially in the PFC, the mPFC surrounds the most anterior part of the 
dorsal cingulate gyrus. Comprised of five main subdivisions – anterior cingulate cortex, 
prelimbic cortex, infralimbic cortex, shoulder cortex, and lateral orbital areas – the mPFC 
receives projections from the hippocampus, amygdala, ventral tegmental area, and 
nucleus accumbens, and projects to most subcortical regions of the brain (Zilles, 1985). 
Traditionally, the mPFC has been implicated in attentional processes, working memory, 
general motility, processing and integrating emotion/affect, theory of mind, and 
behavioral flexibility (Fuster, 2001; Heidbreder & Groenewegen, 2003). Interestingly, 
numerous imaging studies of the mPFC in clinical ASD populations have identified 
abnormal activity. More specifically, reduced or deviant activation of the mPFC has been 
shown during a variety of social (Happe et al., 1996; Pierce, Haist, Sedaghat, & 
Courchesne, 2004; Neuhaus, Beauchaine, & Bernier, 2010), executive function (Gilbert, 
Bird, Brindley, Frith, & Burgess, 2008), and cognitive tasks (Kennedy, Redcay, & 
Courchesne 2006), leading to the idea of altered mPFC activation and neocortical 
connectivity in ASD. Moreover, abnormally patterned and increased short-distance 
functional connectivity within the mPFC, but reduced long-distance reciprocal 
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connectivity between the PFC and other brain regions, is postulated to underlie the 
impaired executive and other higher-order processes seen in ASD (Courchesne & Pierce, 
2005; Rinaldi et al., 2008). For the purpose of this thesis, the Cg3 subdivision of the 
mPFC, as determined by Zilles (1985), will be examined.  
The OFC is located along the rhinal fissure, forming the anterior insular region of 
the PFC, as well as the tissue on the ventral surface of the frontal pole. Subdivided into 
medial and lateral portions; the OFC is well connected with the mPFC, as well as outside 
– including limbic areas (hippocampus and amygdala), sensory areas (somatic sensory, 
olfaction, vision, and taste) and midbrain structures (Price, 2006). The OFC is believed to 
play a major role in response inhibition, the exclusionary aspect of attention, filtering 
extraneous cognitive information, control of mood, social regulation, empathy, and 
aspects of reward and decision making mechanisms with a special emphasis on olfactory 
inputs (Cavada & Schultz, 2000; Fuster, 2001; Ventola et al., 2013). Moreover, the 
highly functional and reciprocal relationship between the OFC and amygdala permits the 
modulation and maintenance of intra-specific social bonding, as well as the self-
regulation of emotional states, thus, subserving the processes of social-cognition and 
emotion functioning which are thought to be highly dysregulated in ASD (Bachevalier & 
Loveland, 2006). In fact, a number of studies in clinical ASD populations have identified 
abnormalities in OFC (amid a series of interconnected brain structures), suggesting a 
dysfunctional neural network (Kawasaki et al., 1997; Dawson, Meltzoff, Osterling & 
Rinaldi, 1998; Schultz, Romanski, & Tsatsanis, 2000; Zilbovicius et al., 2001; Ashwin, 
Baron-Cohen, Wheelwright, O’Riordan, & Bullmore, 2007). Interestingly, Bachevalier & 
Loveland (2006) posit that dysfunction of the OFC may lead to an observed loss of social 
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skills around the second year of life – an idea that is consistent with the 
manifestation/diagnosis of social impairment in children with ASD. For the purpose of 
this thesis, the AID subdivision of the OFC, as determined by Zilles (1985), will be 
examined. 
 
1.1.3.2. Amygdala 
Considered the epicenter of emotion, the amygdala is located in the anterior 
portion of the medial temporal lobe and is comprised of thirteen interconnected nuclei, 
including the lateral, central, and basal nuclei. Briefly, the lateral nucleus receives visual 
(facial expressions, gaze direction, body postures) and auditory (vocal sounds and 
intonations) information and can, reciprocally, modulate the cortical processing of 
sensory information (affective and emotional states). The central nucleus of the 
amygdala, in contrast, is deemed to influence the endocrine and autonomic 
manifestations of emotion via projections to the brainstem and hypothalamus. Namely, 
this pathway can elicit activation of emotional reactions and responses. Finally, the basal 
and accessory basal nuclei project to the ventral striatum, enabling action by subcortical 
elements of the motor system in response to incoming affective information from these 
nuclei (Amaral, 1992; Rolls, 1999; Bachevalier & Loveland, 2006).  
Given the large role of amygdalar nuclei in various aspects of social and 
emotional processing, it is likely that dysregulation of this structure is involved in the 
genesis of ASD. In fact, lack of regional activation during facial processing and 
recognition (Baron-Cohen et al., 2000; Critchley et al., 2000), and increased grey matter 
amygdalar volume (Abell et al., 1999; Waiter et al., 2004) have consistently been 
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demonstrated in clinical ASD populations. Moreover, increases in amygdalar volume 
have been shown to be highly correlated with impaired facial recognition and symptom 
severity (Howard et al., 2000; Sparks et al., 2002). As such, disordered patterns of socio-
emotional behavior in ASD may, in part, be attributed to amygdalar dysfunction and/or 
alterations in circuitry. 
 
1.1.4. Treatment Options for ASD 
  Despite the plethora of research surrounding the possible neurobiological causes 
of ASD, the etiology of the disorder still remains elusive. As a result, current treatment 
options have only been targeted treatments of ASD symptomology, as opposed to the 
underlying cause. In the past few decades, a myriad of treatment options and 
interventions have been developed with the aim to improve social, communicative, and 
motor functioning in ASD populations. Additionally, given the likelihood of comorbid 
behavioral issues associated with ASD, clinicians often adopt a multifaceted approach to 
treatment. Behavioral intervention and pharmacological treatment constitute the two 
major therapeutic approaches to ASD.  
Psychopharmacological treatments seek to alleviate core ASD symptomology, as 
well as concomitant comorbid behaviors (Ventola et al., 2013). Atypical antipsychotics, 
such as risperidone, have proven effective in tempering aggression, self-injury, and 
irritable behaviors often associated with ASD (McDougle et al., 1998; McCracken et al., 
2002; Schneider & Przewlocki, 2011). Additionally, other medications including 
psychostimulants (e.g. methylphenidate), serotonin reuptake inhibitors (e.g. fluoxetine, 
clomipramine), and presynaptic noradrenergic blocking agents (e.g. clonidine) have also 
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been shown to attenuate symptoms of hyperactivity, self-injury, and irritability (Myers, 
2007). More recently, intranasal oxytocin administration in children and adults with ASD 
has exhibited great efficacy as a pharmacological agent. Marked improvements in social 
cognition (Bartz & Hollander, 2008), social motivation (Andari et al., 2010), and a 
reduction in repetitive behaviors (Hollander et al., 2003) were observed, suggesting 
enhanced social functioning and salience as a consequence of oxytocin administration. 
In contrast, behavioral, or psychosocial, intervention seeks to target and improve 
behavioral functioning by focusing on the techniques of learning and behavioral change. 
Treatments have been aimed at attenuating restricted interests and impaired social 
behaviors while reinforcing the proper use of language and social strategies (Lovaas, 
Koegel, Simmons, & Long, 1973; Ventola et al., 2013). Applied behavioral analysis 
(ABA), for instance, adopts a systematic approach of skill acquisition in children with 
ASD to reinforce desired behaviors and reduce undesired behaviors (Lovaas et al., 1973; 
Vismara & Rogers, 2010; Ventola et al., 2013). Additionally, pivotal response treatment 
(PRT), another intensive behavioral therapy, builds upon the foundations of ABA and 
promotes naturalistic skill acquisition in social and communicative domains, by 
addressing the child’s social motivation (Koegel & Koegel, 2012; Ventola et al., 2013).  
While several pharmacological treatments and behavioral modification therapies 
have proven to be effective in the attenuation of ASD symptomology, limited success of 
any treatment modality – individual or combined – to completely reverse core autistic 
traits have been met.   
 
1.1.4.1. Massage/Touch Therapy  
 
 
 
 
12 
Infant massage, or touch therapy, constitutes another alternative behavioral 
approach that has been shown to be effective in attenuating autistic symptoms. Physical 
in nature, touch therapy has been demonstrated to have a positive physiological and 
psychological impact on infant development that far exceeds the immediate sensation 
(Field et al., 1996). During development, exposure to touch not only influences the 
mother-infant attunement and co-regulation, but also infant brain development (Jones & 
Mize, 2007). More specifically, touch therapy during infancy profoundly influences 
cognitive, motor, social, and physiological development, and may play a pivotal role in 
the socialization of higher-order emotional processes (Wyschograd, 1981; Ottenbacher et 
al., 1987; Weber, 1990) – further illuminating touch as a potent avenue for intervention.  
As revealed similarly in premature infants, infants of depressed mothers, and 
other high-risk groups (e.g. orphans and infants suffering from Cerebral Palsy), touch 
therapy in children with ASD proves to be beneficial by promoting neurobehavioral 
development, thus improving the child’s overall outcome (Jones & Mize, 2007). 
Improvements in verbal and nonverbal communication skills, sleeping patterns, increased 
on-task behavior and social relatedness, increased attentiveness in the classroom, fewer 
stereotypical autistic behaviors, and decreased touch aversion were reported in ASD 
children following touch intervention in early childhood (Field et al., 1997; Escalona, 
Field, Singer-Strunck, Cullen, & Hartshorn, 2001; Cullen, Barlow, & Cushway, 2005a; 
Jones & Mize, 2007). Thus, it appears that massage therapy is an effective intervention in 
attenuating various social and communicative behavioral issues in children with ASD, 
further insinuating the importance of early sensory input on the developing autistic brain.  
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1.2. Animal Models of ASD 
 Despite decades of research, the etiology of ASD remains undetermined. In recent 
years, however, converging lines of evidence suggest that most cases of ASD arise from a 
complex interaction of genetic predisposition and strong environmental influence. Thus, 
in order to elucidate the neural basis of this complicated and unique human disorder, it is 
important to pursue all avenues – molecular, cellular, genetic, and behavioral levels – 
underlying ASD. Animal models, particularly rodents, have proven to be a highly 
valuable tool for the study of ASD. More specifically, animal models may be utilized to 
study the neural pathways, cellular and molecular anomalies, roles of genes and the 
environment, and the application of therapeutic treatments – all of which may be 
implicated in the pathogenesis of ASD. Currently, animal models of ASD can be 
categorized into three general approaches: 1) models based on neurobiological anomalies 
– neurophysiological or neurochemical in nature; 2) genetically modified animal models 
– targeted mutations in genes; and 3) environmentally induced animal models – pre- and 
perinatal exposure to teratogens and/or immunological infections (Schneider & 
Przewlocki, 2011). In the present chapter, we will briefly examine genetic and insult-
based etiological animal models of ASD to illustrate the translational value of such 
models in reproducing behavioral and pathological symptoms characteristic of human 
ASD. Moreover, the valproic acid (VPA) rodent model of ASD – an environment-insult 
based model – will be discussed in detail, as the behavioral and neuroanatomical 
characterization of this model constitutes the studies presented in this thesis.  
 It is important to note that given the tremendous phenotypic variability in ASD, 
an ongoing challenge for the development of a translational animal ASD model is the 
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extent to which the model encompasses the many clinical hallmarks of ASD. That is, 
should animal models replicate all pathophysiological aspects (behavioral, genetic, and 
neuroanatomical), or particular features of the disorder? Resolution of this conundrum 
lies primarily in the goal or question the model wishes to validate. For instance, modeling 
ASD symptomology (face validity) versus simulation of the underlying mechanisms 
(construct validity) ought to be considered when evaluating criterion for animal models 
of ASD and other psychiatric disorders (Tordjman et al., 2006; Schneider & Przewlocki, 
2011). 
 
1.2.1. Genetic Characterization 
 Given the extraordinarily heritable nature of ASD, genetically altered animal 
models offer promising new developments in studying the etiology of this intrinsically 
complex disorder. Most genetically induced rodent models of ASD are based on the 
manipulation of candidate genes or pathways that have been identified and characterized 
in subsets of human ASD populations (Moy, Nadler, Magnuson, & Crawley, 2006). 
Moreover, the customary strategy for genetic modification involves the creation of a null 
allele, where targeted disruption of a loci segment prevents the production of functional 
proteins (i.e. chromosomal deletions and knockout mutations). Additionally, generation 
of an ASD-associated allele (i.e. knock-in mutation) is an alternative approach to 
generate analogous mutations in the rodent genome (Moy et al., 2006; Silverman, Yang, 
Lord, & Crawley, 2010).  
 In developing genetically engineered rodent models of ASD, it is important to 
note that despite the strong genetic component, ASD is not a monogenic disorder. That is, 
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whereas single-gene mutants do offer insight into some features of ASD, they are not 
absolute or directly relevant models. In fact, it has been suggested that the number of loci 
associated with ASD in clinical populations exceeds 15 (Risch et al., 1999), leading to 
the idea that ASD is far more complex than initially thought, and that a single loci or 
factor cannot account for the multifaceted nature of the disorder (Moy et al., 2006). 
Nonetheless, there are several genetically modified mice and rat models that share 
behavioral features analogous to human ASD symptomology. 
 For instance, the BTBR T+tf/J (BTBR) mouse model is a genetically homogenous 
inbred strain that displays great behavioral similarity to the two diagnostic domains of 
symptoms in ASD. Reductions in sociality and reciprocal social interactions, altered 
ultrasonic vocalizations in pups and adults, and increased frequency of repetitive self 
grooming all encompass the behavioral phenotype of BTBR mice that is relevant to 
human ASD (Silverman et al., 2010; Meyza et al., 2013). Additionally, whereas 
neuroanatomical and physiological similarities to human ASD have also been 
demonstrated in BTBR mice – such as the Disc1 mutation, for example – only a fraction 
of human ASD cases appear to possess these alterations (Kilpinen et al., 2008; Crepel et 
al., 2010; Meyza et al., 2013).  
 Nlgn4 mice constitute another genetically altered animal model of ASD that 
exhibits a behavioral phenotype reflecting social deficit. Mutation in the human NLGN4 
gene is implicated in the pathogenesis of ASD, as NLGN4 encodes an important post-
synaptic cell adhesion protein (Jamain et al., 2003). As such, a null mutation in the 
murine orthologue of the NLGN4 gene produces mutant mice exhibiting an ASD-like 
behavioral phenotype, particularly in the social and communicative domains (Jamain et 
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al., 2003; Jamain et al., 2008; El-Kordi et al., 2013; Wohr & Scattoni, 2013a, b). In sum, 
these two genetic mice models of ASD provide a sample of the wide range of rodent 
models available for elucidating the origins of ASD. It is evident that manipulation of 
candidate genes may reproduce behavioral and neuroanatomical phenotypes comparable 
to human ASD.  
 
1.2.2. Environmental Characterization 
 Exposure to a multitude of environmental factors during embryogenesis has long 
been implicated in the pathogenesis of ASD. Given the degree of ecological validity 
associated with environmental risk factors, insult-based animal models of ASD have been 
valuable in elucidating the complex relationships underlying ASD. Ranging from pre- 
and perinatal exposure to thalidomide (Narita et al., 2002), VPA (Ingram, Peckham, 
Tisdale, & Rodier, 2000), ethanol (Arndt, Stodgell, & Rodier, 2005), and pre- and 
postnatal viral infections (Lancaster, Dietz, Moran, & Pletnikov, 2007; Chess, Fernandez, 
& Korn, 1978), environmentally-induced animal models of ASD have been proposed and 
evaluated on the basis of behavioral, genetic, and neuropathological similarities to the 
human disorder.  
 An extensive body of epidemiological research has clearly established the link 
between maternal use of VPA during pregnancy and the increased incidence of ASD – a 
4.42% absolute risk (Williams et al., 2001; Bromley et al., 2013; Christensen et al., 2013; 
Roullet, Lai, & Foster, 2013). Given the many health risks associated with VPA use 
during pregnancy and the childbearing years, simulation of clinical endpoints and 
behavioral phenotyping in animals models have provided further insight into the impact 
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of VPA on the developing brain and the emergence of ASD (Roullet et al., 2013). Several 
independent laboratories have demonstrated that in utero exposure to VPA induces 
abnormal patterns of somatic and physiological development across a variety of species 
including rabbits (Petrere, Anderson, Sakowski, Fitzgerald, & de la Iglesia, 1986), rhesus 
monkeys (Mast, Cukierski, Heinz, & Hendrickx, 1986), and especially rodents (Brown, 
Kao, & Fabro, 1980; Bruckner, Lee, O’Shea, & Henneberry, 1983; Nau, Hauck, & 
Ehlers, 1991; Ehlers, Sturje, Merker, & Nau, 1993; Sonoda, Ohdo, Ohba, Okishima, & 
Hayakawa, 1993; Mengola, Broccia, Prati, & Giavini, 1998). In fact, in 1996, Rodier and 
colleagues established the VPA rodent model of ASD to further elucidate the mechanism 
of its teratogenic action (Rodier, Ingram, Tisdale, Nelson, & Romano, 1996; Rodier, 
Bryson, & Welch, 1997a). This model exhibits striking behavioral, neuropathological, 
cellular, and immunological similarities to the ASD phenotype, validating the 
multidimensional approach of the VPA model in elucidating the clinicopathology of ASD 
(Rodier, Ingram, Tisdale, & Croog, 1997b; Dufour-Rainfray et al., 2011; Schneider & 
Przewlocki, 2011; Roullet et al., 2013). Decreases in social interactions, increased 
repetitive/stereotypic activity, abnormal responses to painful and non-painful stimuli, 
increased anxiety, alterations in pup ultrasonic vocalizations (USVs), and early signs of 
neurodevelopmental delay all encompass the wide repertoire of impaired behavioral 
functioning consequent of prenatal VPA exposure (Schneider & Przewlocki, 2005; 
Roullet et al., 2013). Moreover, on an anatomical and cellular level, rats prenatally 
exposed to VPA exhibit reduced cranial nerve motor nuclei, significant diminution of 
cerebellar Purkinje cells, hypoplasia of brainstem structures, reduced volume of posterior 
portions of cerebellar vermis and hemispheres, injury of cerebellar deep nuclei, and 
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decreases in the spine density of forebrain structures, paralleling many neuropathological 
findings reported in human ASD (Rodier et al., 1996; Rodier et al., 1997a, b; Courchesne, 
1997; Ingram et al., 2000). Thus, given the remarkable similarities between the VPA 
rodent model of ASD and the human condition, it is evident that this model is a viable 
experimental platform to further elucidate the neurobiological mechanisms underlying 
the origins of ASD. 
 
1.3.  Objective of Thesis 
 The present studies were aimed at investigating the validity of in utero VPA 
exposure in simulating the brain developmental disturbances equivalent to those seen in 
human ASD. Specific objectives achieved in the present thesis include: 
1. To investigate the effect of in utero VPA exposure on offspring lifelong behavior 
in social, communicative, emotional, cognitive, and motor domains;  
2. To investigate the plastic changes associated with in utero VPA exposure, in brain 
regions implicated in ASD; and, 
3. To investigate the therapeutic effect of early tactile stimulation – an enriching 
experience – in attenuating the behavior and neural underpinnings of in utero 
VPA exposure. 
 
1.4. Hypotheses 
The following hypotheses guided the research: 
 
 
 
 
19 
1. Prenatal exposure to a single dosage of VPA will produce behavioral and 
neuroanatomical characteristics equivalent to human ASD (face and construct 
validity); and, 
2. An early enriching experience of tactile stimulation will attenuate or remediate 
the VPA-induced behavioral and neuroanatomical changes in rats (predictive 
validity). 
 
1.5. Organization of Thesis 
 The present thesis includes two experiments, both utilizing an acute high dosage 
paradigm of prenatal VPA to simulate a translational model of ASD. Experiments are 
presented as individual manuscripts, each of which has been submitted to a journal for 
publication. 
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CHAPTER 2 
The Effects of Prenatal Exposure to Valproic Acid on the Development of Juvenile-
Typical Social Play in Rats∗  
 
2.1. Abstract 
Autism is a severe neurodevelopmental disorder characterized by qualitative impairments 
in social behavior, communication, and aberrant repetitive behaviors.  A major focus of 
animal models of autism has been to mimic the social deficits of the disorder. The present 
study assessed whether rats exposed prenatally to valproic acid (VPA) exhibit deficits in 
social play as juveniles that are consistent with the social deficits seen in autism. Dams 
were exposed to an acute dose of VPA on gestational day 12.5. Later, the playful 
interactions and associated ultrasonic vocalizations (USVs) of the juveniles were 
examined. It was predicted that VPA-treated rats should play less than the controls. 
Characteristic of neurobehavioral insult at this early age, the VPA-treated juveniles 
exhibited significant increases in the frequency of body shakes and sexual mounting, but 
played at the same frequency as the controls. However, when playing, they were less 
likely to use tactics that facilitated bodily contact and vocalized less. These data suggest 
that prenatal VPA exposure disrupts some aspects of being able to communicate 
effectively and engage partners in dynamic interactions – deficits that are consistent with 
those seen in autism.  
 
                                                
∗Raza, S., Himmler, B.T., Himmler, S.M., Harker, A., Kolb, B., Pellis, S.M., & Gibb, R. 
(2015). The Effects of Prenatal Exposure to Valproic Acid on the Development of 
Juvenile-Typical Social Play in Rats. Submitted to Behavioral Pharmacology. 
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2.2. Introduction 
Autism is a pervasive neurodevelopmental disorder characterized by impairments 
in social interaction and communication, and by highly stereotypic behaviors and/or 
restricted interests. Owing to the heightened awareness and shifting diagnostic criteria 
over the past decade, the prevalence of autism has seen a significant rise: seemingly 
affecting 1 in 68 children (Centers for Disease Control and Prevention, 2014). Despite 
decades of research, the etiology of autism remains elusive. Recently, however, several 
lines of converging evidence strongly suggest that the interplay between environmental 
and genetic factors may be contributing to the behavioral pathologies seen in autism 
(Hallmayer et al., 2011; Ronald & Hoekstra, 2011). For this reason, preclinical research 
is now focusing on the development of transgenic and environmental animal models of 
autism to understand the genotype-phenotype relationship better, as well as the 
neurobiological mechanisms that underlie the disorder (Bolivar, Walters, & Phoenix, 
2007; Banerjee et al., 2014). Validation of these animal models of autism is contingent 
upon the ability to simulate the distinctive clinical features of autism, such as the deficits 
in aspects of social function (Wöhr & Scattoni, 2013a, b).  
Retrospective studies on human subjects have demonstrated that in utero exposure 
to VPA –a teratogenic anticonvulsant – during the first trimester of pregnancy leads to an 
increased incidence (4.42% absolute risk) of autism and intellectual disability 
(Christianson, Chesler, & Kromberg, 1994; Moore et al., 2000; Rasalam et al., 2005; 
Christensen et al., 2013). Owing to this correlation between in utero VPA exposure and 
the increased risk of autism, the VPA rodent model was developed (Rodier et al., 1996; 
Arndt et al., 2005; Bromley, Baker, & Meador, 2009; Bath & Sharfman, 2013; Bromley 
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et al., 2013). Pregnant dams exposed to a single dose of VPA on gestational day 12.5 
produce progeny that exhibit behavioral and neuroanatomical anomalies that are similar 
to those present in humans with autism (Rodier et al., 1996; Rodier et al., 1997a, b; 
Schneider & Przewlocki, 2005; Rinaldi et al., 2008; Snow, Hartle, & Ivanco, 2008; 
Mychasiuk, Richards, Nakahashi, Kolb, & Gibb, 2012; Chomiak, Turner, & Hu, 2013). 
A potentially useful behavioral assay of the kinds of social deficits seen in autism 
is rough-and-tumble play or play fighting (Pellis & Pellis, 1998). Play fighting is an 
affiliative form of behavior that involves many neural systems for its execution and 
regulation (Siviy & Panksepp, 2011; Vanderschuren, Niesink, & Van Ree, 1997), and 
involves complex patterns of inter-animal coordination and communication (Palagi et al., 
2015). That is, play fighting involves the kinds of social abilities thought to be 
compromised in autism. Thus, it is likely that play fighting may not only offer insight 
into the dynamics of social interactions, but may also highlight some of the neural 
mechanisms that are altered or compromised in VPA-exposed rats. Interestingly, 
Schneider and Przewlocki (2005) and Chomiak and colleagues (2010) have demonstrated 
attenuated social play behavior in rats prenatally exposed to VPA, indicating impaired 
sociality. However, while these studies indicate reduced sociality, the measures used to 
evaluate play fighting do not allow for the characterization of altered behavioral 
mechanisms (e.g., Bell, McCaffrey, Forgie, Kolb, & Pellis, 2009; Pellis, Pellis, & 
Whishaw, 1992) that led to this reduction in play. Also, rats emit high frequencies of 
ultrasonic vocalizations (USVs) in the 50-kHz range during play (Brunelli et al., 2006; 
Burgdorf et al., 2008), which may have a potential communicatory role during play 
(Himmler, Kisko, Euston, Kolb, & Pellis, 2014; Kisko, Himmler, Himmler, Euston, & 
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Pellis, 2015). Therefore, in the present study, a detailed analysis of play fighting 
involving the scoring of the attack and defense tactics used (Himmler, Pellis, & Pellis, 
2013) and the frequency of the 50-kHz calls emitted (Burgdorf et al., 2008; Wright, 
Gourdon, & Clarke, 2010) was conducted on prenatally exposed VPA rats. Pregnant 
dams were exposed to an acute high dose of VPA on gestational day 12.5, and the 
resultant female progeny were tested between 29 and 34 days of age, which is within the 
peak period of playful interactions in rats (Thor & Holloway, 1984). Females were 
utilized to avoid potential dominance effects typically seen in male rats (Pellis, Field, 
Smith, & Pellis, 1997).  
It was hypothesized that if exposing rats prenatally to VPA rats is a suitable 
animal model of autism, the reduced playfulness previously reported (Schneider & 
Przewlocki, 2005; Chomiak, Karnik, Block, & Hu, 2010) should arise from a reduction in 
the use of playful tactics that promote sustained body contact and there should be a 
reduction in the emission of 50-kHz calls associated with play. That is, the rats should 
have impairments in the skills that lead to fast-paced and coordinated playful interactions. 
 
2.3. Methods 
2.3.1. Subjects 
Thirty-two female Long-Evans rats (16 VPA and 16 control) born to 3 VPA-
exposed and 3 control dams were used. All subjects remained with their mothers until 
weaning on postnatal (PN) day 22, when they were randomly paired with a group- and 
age-matched (within 3 days) partner. Pairs were housed in standard polycarbonate 
shoebox cages (46cm X 25cm X 20cm) and maintained on a 12hr light/12hr dark diurnal 
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cycle. Food and water were available ad libitum. Animals were born and raised in the 
vivarium maintained at the Canadian Centre for Behavioural Neuroscience, University 
Lethbridge. All experimental protocols were approved in accordance with the Canadian 
Council of Animal Care and the University of Lethbridge Animal Care Committee. 
 
2.3.2. VPA Administration 
Pregnant dams were administered VPA orally on gestational (G) day 12.5. Prior 
to VPA administration, all dams were spoon-fed 1.5g of peanut butter for three 
consecutive days. On G12.5, half of the dams received 800mg/kg of VPA mixed with 
peanut butter, while the remaining dams received peanut butter alone. 
 
2.3.3. Testing Enclosure and Measurement of Ultrasonic Vocalizations 
Play trials were conducted in a Plexiglas® box, measuring 50cm X 50cm X 50cm, 
with 1-2cm of CareFresh® bedding. The Plexiglas® box was enclosed in a soundproofed 
chamber (inside measurements: 59cm X 65.5cm X 81.5cm). The soundproofed chamber 
contained sound-attenuating foam and an ultrasonic microphone (Model 4939, Brüel & 
Kjaer, Denmark) located 32-38cm above the chamber floor. The microphone was 
connected to a SoundconnectTM amplifier (Listen, Inc, Boston, MA) that processed all 
recordings via a multifunction processor (RX6, Tucker-Davis Technologies, Alachua, 
CA) on a desktop in the testing room. The multifunction processor was programmed with 
MATLAB. The receiver recorded frequencies ranging from 4- and 100-kHz and all files 
were, subsequently, converted to .wav files. The play trials were filmed using a DVD103 
Sony Handycam with night-shot capacity, elevated at a 45° angle. Off-line analysis was 
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performed using Raven Pro 1.4 software (Cornell University, Ithaca, NY) for audio files, 
while Avidemux 2.6 software was used for video files. 
 
2.3.4. Procedure 
Play fighting was assessed between PN29-PN34, the age at which playful 
interactions are most frequent in rats (Thor, & Holloway, 1984). Three days prior to 
testing, the rats were habituated, in pairs, to the play enclosure for 30 min/day, then prior 
to testing, the rats were socially isolated for 24 hours, to ensure enhanced playfulness 
when introduced to the experimental enclosure (Panksepp & Beatty, 1980; Niesink & 
Van Ree, 1989; Pellis & Pellis, 1990). Test sessions lasted for 10-min, providing 
sufficient time to capture a large sample of playful interactions (Pellis & Pellis, 1990). 
Pairs of rats were placed in the test enclosure, one at a time, and recording began once 
both rats were inside the enclosure. Given that the vocalizations and play behavior were 
recorded on separate devices, the audio and video files were synchronized via a device 
emitting a simultaneous light/sound cue. At the beginning of each trial, three consecutive 
cues were emitted. Trials were considered to have begun during the onset of the third 
beep (Himmler et al., 2014). Each pair was tested twice, with a 24-hour rest interval 
between the two trials. Both habituation and testing occurred in complete darkness, as the 
frequency of social behaviors has been demonstrated to increase in the dark (Pellis & 
Pellis, 1987, 1990, 1997; Smith, Forgie, & Pellis, 1998; Foroud & Pellis, 2002). 
 
2.3.5. Behavioral Analyses 
Following collection of behavioral data, each 10-min play session was scored for 
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attack and defense (Pellis & Pellis, 1987). A playful attack was scored when one rat 
moved its snout towards the nape of the other, or actually contacts the nape with the 
snout. The response of the recipient of the attack was then scored. The recipient could 
either show no response and simply continue with its preceding activity (e.g., walking, 
manipulating the substrate) or defend against the imminent contact. Playful defense 
involves either evasion, whereby the defender moves its nape away from the attacker 
while simultaneously also turning its face away from the partner, such as by running, 
pivoting, or leaping, or by facing defense, whereby the defender moves its nape away 
from the attacker while turning to face the partner. In doing so, the defender opposes its 
teeth between its attacker and its own nape, thereby blocking access to the nape. Facing 
defense may take one of three forms: (a) complete rotation, where the defender rolls 
completely over onto its back, (b) partial rotation, where the defender rotates its 
forequarters, but ground contact with one or both of its hind feet is maintained, and (c) 
other, where rotations or movements in other dimensions are executed (Pellis et al., 
1992). The defensive maneuver that was first attempted by the defending rat (as seen in 
the first 2-3 frames) was scored (Himmler et al., 2013). In addition, given that that the 
studies by Schneider and Przewlocki (2005) and Chomiak et al. (2010) used the 
frequency of pinning as their measure of play, this was also scored. A pin is scored when 
one rat lies on its back with all four paws freed from contact with the ground and the 
partner stands over it (Panksepp, 1981). The absolute frequency of this on-bottom/on-top 
configuration over the trial was scored. To investigate the effects of prenatal VPA 
exposure on play fighting, the frequency of pins and playful attacks per trial was 
calculated, as was the probability of defense against attacks. When a defense did occur, 
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the probability of using each of the different defensive tactics was also calculated. 
Given the previous findings on the effects of VPA on play (Schneider & 
Prezwlocki, 2005; Chomiak et al., 2010), it was predicted that all the measurements that 
reflect the motivation to play (frequency of playful attacks, frequency of pinning, 
probability of defense) (Panksepp, 1981; Reinhart, Pellis, & McIntyre, 2004; Thor & 
Holloway, 1983), should decrease in the VPA-treated rats as compared to the controls. 
Alternatively, if the reduction in pinning revealed by the previous studies arose because 
of changes in how the VPA-treated rats defended themselves (Bell et al., 2009; Pellis et 
al., 1992), then it was predicted that the use of the complete rotation tactic would be 
reduced, and either evasion would increase if the rats were avoiding contact (Varlinskaya, 
Spear, & Spear, 1999) or one of the standing defenses would increase if the rats stood 
their ground to fend off the partner’s attack (Reinhart et al., 2004).   
In addition to playful attack and defense, four other behaviors were scored during 
the 10-min trials. In rats, as in other murid rodents (Pellis, 1993), play fighting involves 
competition for a body target, which for rats is the nape (Pellis & Pellis, 1987; Siviy & 
Panksepp, 1987), a target that is contacted by males during pre-copulatory interactions in 
adults. Sometimes, especially as the rats approach sexual maturity, the likelihood that 
playful interactions include mounting increases (Pellis & Pellis, 1990). Similar to 
copulatory behaviors in sexually mature male and female rats, mounting involves one 
animal approaching the partner from the rear, grasping its partner’s flanks with its 
forepaws and making ventro-dorsal body contact. Such contact may also include pelvic 
thrusting, but without intromission. Both the playful competition for the nape and 
mounting is present in both males and females (Meaney & Stewart, 1981; Pellis & Pellis, 
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1990). Higher frequencies of mounting during play trials may indicate the precocial 
maturation of sex, a characteristic of autism reported in humans, especially in females 
(Dalldorf, 1983; Realmuto & Ruble, 1999). Therefore, the frequency of mounting was 
also scored during the play trials and it was predicted that the VPA-treated rats would 
mount more frequently.  
During playful interactions, rats will occasionally jump, rotate, and shake their 
heads and bodies (Pellis & Pellis, 1983). However, when stressed, rats will show 
exaggerated rates of head and body shaking. In addition, stressed rats will increase their 
frequency of scratching the anterior of their body with their hind paws, and will engage in 
short duration, highly stereotyped bouts of grooming. These behaviors have been used in 
rats and other animals as markers of stress (Redmond & Huang, 1979; Van Hooff & 
Aureli, 1994; Van Den Bos, 1998; Komorowska & Pellis, 2004; Reinhart et al., 2004; 
Norscia & Palagi, 2011). Given that changes in play may result from changes in anxiety 
or stress, rather than to changes in being able to follow social rules and communicate 
effectively, head and body shakes, scratches, and stereotyped grooming were scored for 
their frequency over the duration of the trials. Moreover, increased head and body 
shaking has been reported as a side effect of postnatal treatment with VPA (Handley, & 
Singh, 1986; Fletcher, & Harding, 1981; Loscher & Honack, 1996) and may also be 
indirectly associated with prenatal treatments, given the influence of VPA on 
serotonergic systems which also increase the frequency of such shakes (Narita et al., 
2002; Kuwagata, Ogawa, Shioda, & Nagata, 2009; Dufour-Rainfray et al., 2010). If this 
shaking increased along with scratching and stereotyped grooming, then it would likely 
signify that it may have arisen as a by product of stress, but if it alone increased, it would 
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reflect the VPA treatment did have a direct teratogenic effect. Therefore, it was predicted 
that shaking would increase in the VPA-treated rats, whether the other markers for stress 
did so or not. 
Higher frequencies of play are correlated with higher rates of emitting 50-kHz 
calls (e.g., Brunelli et al., 2006; Burgdorff et al., 2008; Knutson, Burgdorf, & Panksepp, 
1998), therefore, conversely, if VPA-treatment reduces play, there should be an 
associated reduction in the frequency of calling. To evaluate this possibility, the overall 
frequency of calling was scored. Due to the high number of calls, for quantitative 
comparisons only the calls emitted in the first 5-min of each trial were scored. Given that 
the highest frequency of play by rats is within the first five minutes after introduction to 
the test enclosure (Panksepp & Beatty, 1980; Panksepp, 1981) and that calling is most 
frequent when rats play the most, this truncated sample interval should suffice to evaluate 
any VPA-induced changes. Overall, however, if the frequency of calling follows 
frequency of play, the rate of calling per bout of play fighting (i.e., total number of 
calls/total number of play fights) should remain the same. To confirm that the frequency 
of calling fluctuated with the frequency of playing, the minute-by-minute occurrence of 
calling was compared to the minute-by-minute occurrence of play. It was predicted that if 
play was reduced in the VPA-treated rats, then the frequency of emitting ultrasonic calls 
would also be reduced, and that this reduction would be reflected in the above 
measurements.  
 
2.3.6. Statistical Analysis 
All statistical analyses were performed on SPSS 21 for Mac. For pairwise 
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comparisons with a predicted direction of treatment effect, independent one-tailed 
Student’s t-tests were used and for cases in which a direction of effect was not predicted, 
two-tailed t-tests were used. For multiple pairwise comparisons that did have a predicted 
outcome, a Bonferroni correction was used to correct the alpha value. For the minute-by-
minute comparison of the frequency of playful attacks with the frequency of calling, a 
repeated measures two-way ANOVA with group and time as the factors of interest was 
used. The significance level was set at ≤ 0.05 for all the analyses. All graphical 
representations of the data represent the means and standard errors. 
 
2.3.7. Inter-Observer Reliability 
The videotapes were all scored by one observer (S.R). To ensure a high degree of 
consistency in scoring, a subset of trials (6 pairs; 3 VPA, 3 control) were re-scored for 
playful attack, probability of defense, total number of pins, complete rotation defense, 
and evasive defense by another observer (S.M.H.), as were the frequency of vocalizations 
occurring in these trials (B.T.H.). The values obtained by these second scorers were 
compared to those of the primary scorer (S.R.) using the Pearson’s correlation, which 
revealed a significantly high degree of inter-observer reliability for all measures: values 
ranged between 0.774 and 0.986, with five of six being significant, p < 0.05. For the 
purposes of this paper, all data shown are values derived from the primary scorer (S.R.). 
 
2.4. Results 
2.4.1. Frequency of Play 
VPA and control rats did not differ significantly either in their frequency of 
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launching nape attacks [t(14) = 1.149, p = 0.270] (Figure 2.1A) or in the probability of 
defending against a nape attacks [t(14) = 0.0270, p = 0.979] (Figure 2.1B).  Similarly, 
there was no significant difference in the frequency of pins [t(14) = 0.784, p = 0.446] 
(Figure 2.1C). 
 
2.4.2. Frequency of Defensive Tactics 
The VPA and control rats did not differ in their use of evasion [t(14) = 0.986, p = 
0.341] (Figure 2.2A). With regard to the turning to face defensive tactics, VPA rats were 
significantly less likely to turn to supine [t(14) = -2.513, p = 0.025] (Figure 2.2B) and 
significantly more likely to remain standing, using “other” defense tactics [t(14) = 2.822, 
p = 0.014] (Figure 2.2C). There was no significant difference in the probability of using 
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Figure 2.1. (A) The total number of playful attacks per 10 minute play trial. (B) The 
probability of defending against a playful attack. (C) The total number of pins per 10 
minute play trial. 
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the partial rotation tactic [t(14) = -1.984, p = 0.067]. 
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Figure 2.2. (A) The probability of using evasive tactics when defending against a 
playful attack. (B) The probability of using the complete rotation tactic when 
defending against a playful attack. (C) The probability of using standing, or other 
tactics when defending against an attack. 
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2.4.3. Sexual and Anxiety-Like Behaviors 
VPA rats mounted each other significantly more often than did the control rats 
[t(14) = 4.241, p = 0.001] and were significantly more likely to perform head and body 
shakes [t(14) = 2.570, p = 0.022], but there were no significant differences for either 
scratching [t(14) = -0.132, p = 0.897] or grooming [t(14) = 0.863, p = 0.403] (Table 2.1). 
 
Table 2.1. Mean (± SE) values for measures of anxiety and sexual behavior in pairs of 
VPA and control rats 
Behavior (#/10min) VPA Pairs Control Pairs t-tests 
Head and Body Shakes 10.25 ± 1.66 5.63 ± 0.71 p = 0.022 
     Scratching 3.75 ± 0.49 3.88 ± 0.81 NS 
     Grooming Bouts 5.25 ± 1.31 4.00 ± 0.63 NS 
     Mounting 12.37 ± 2.59 1.25 ± 0.41 p = 0.001 
 
2.4.4. Ultrasonic Vocalizations 
While the VPA rats tended to call less frequently overall, the difference was not 
statistically significant [t(14) = -1.882, p = 0.081] (Figure 2.3A). The rate of calling, 
however, revealed that the VPA rats called significantly less often than expected for the 
number of times they initiated play [t(14) = -2.683, p = 0.018] (Figure 2.3B). This latter 
finding was corroborated by the minute-by-minute analyses. Repeated measures 
ANOVAs revealed that there was a significant difference in the frequency of play, with 
VPA rats initiating more playful attacks in the first (p = 0.05), second (p = 0.018), and 
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third (p = 0.014) minutes (Figure 2.4A), but emitting fewer calls over these time points, 
an especially in the fifth minute (p = 0.021) (Figure 2.4B). 
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Figure 2.3. (A) The total number of calls emitted per 5 minute play trial. (B) The 
rate of calling per bout of play fighting (total number of calls/total number of play 
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2.5. Discussion 
The first diagnostic criterion for autism, described in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-V), involves qualitative impairments in social 
interaction (American Psychiatric Association, 2013). Poor peer relationships, lack of 
social reciprocity, refusal of body contact, inability to empathize, and 
unusual/inappropriate social approach behaviors all encompass the wide repertoire of 
impaired social functioning in autism (Adrien et al., 1991; Gillberg, Nordin, & Ehlers, 
1996; Seltzer et al., 2003; Sigman, Dijamco, Gratier, & Rozga, 2004; Trevarthen & 
Daniel, 2005; Auyeung et al., 2009; American Psychiatric Association, 2013). As such, 
purported animal models of autism, like fetal exposure to VPA in rodents, need to be able 
to produce similar impairments in social behavior. 
While reduced sociality, measured by a range of behavioral indices, has 
consistently been demonstrated in animal models of autism (Schneider & Przewlocki, 
2005; Markram, Rinaldi, La Mendola, Sandi, & Markram, 2008; Dufour-Rainfray et al., 
2010; Olexová, Talarovicová, Lewis-Evans, Borbélyová, & Krsková, 2012; Wellmann, 
Varlinskaya, & Mooney, 2014), how sociality is reduced is not well understood. Given 
the complex cognitive, emotional, and communicative demands on animals during social 
play (Graham & Burghardt, 2010; Palagi et al., 2015; Pellis, Pellis, & Reinhart, 2010), 
the present study provides a detailed analysis of the social play of rats exposed to VPA as 
fetuses. It was predicted that the previously reported decreases in social play (Schneider 
& Przewlocki, 2005; Chomiak et al., 2010) should be correlated with a reduction in 
contact promoting maneuvers during the play and also a reduction of play-associated 
ultrasonic vocalizations in the 50-kHz range. The data, in the present study, did not 
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support the previous studies, but did reveal changes in the dynamics of play and the 
communication occurring therein.  
The marker revealing a reduction in the frequency of play in the previously 
published papers (Schneider & Przewlocki, 2005; Chomiak et al., 2010) was pinning, in 
which one rat lays supine and the partner stands over it (Panksepp, 1981). Using the same 
measure, we did not find a comparable reduction in play in the present study. Similarly, 
we did not find a significant reduction in playful attacks nor was there a significant 
reduction in the likelihood that playful attacks elicited playful defense. That is, on all of 
these measures of playfulness (Himmler et al., 2013), the VPA-treated rats did not differ 
from the untreated controls, suggesting that the tendency of VPA-treated rats to socialize 
was not diminished. One explanation for this failure to replicate the previous findings is 
that the mode of treatment, ingestion versus injection of VPA, was unsuccessful. This is 
unlikely for several reasons. 
First, mounting was significantly increased in the VPA-treated rats, suggesting that 
the VPA was effective in altering development. Research on autistic populations has 
shown that socially inappropriate behaviors, such as self-stimulatory behaviors, are 
prevalent and may indicate deviations in sexual development (Realmuto & Ruble, 1999). 
The elevated frequency of mounting, especially at this early developmental stage (Pellis, 
1993), suggests that the VPA accelerated the maturation of sexual behavior. Moreover, 
given that the subjects used were female, and females mount much less frequently than 
males (Meaney & Stewart, 1981; Pellis & Pellis, 1990), the VPA may have altered the 
normal development of the neural circuitry involved in regulating sexual behavior.  
Second, some previous research has shown the occurrence of elevated frequencies 
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of stress-related responses, such as excessive scratching, in rats prenatally exposed to 
VPA when tested in anxiety provoking paradigms (Schneider, Ziòłkowska, Gieryk, 
Tyminska, & Przewlocki, 2007; Raza, Harker, Richards, Kolb, & Gibb, 2015). The 
absence of exaggerated rates of either scratching or stereotyped grooming in the present 
study suggests that the VPA exposure did not increase anxiety in the rats but we did find 
a significantly higher frequency of body shaking. Postnatal exposure to VPA has been 
shown to increase the frequency of body shakes and this increase is thought to arise from 
increased serotonin (5-HT) activity (Handley & Singh, 1986; Fletcher & Harding, 1981). 
There is debate, however, on the influence of VPA on the occurrence of body shakes via 
5-HT transmission, given the absence of increased body shakes following exposure to 
trans-2-en-VPA, the major metabolite of VPA (Nau & Loscher, 1984; Loscher, Honack, 
Nolting, & Fassbender, 1991; Loscher & Honack, 1996). Nonetheless, it seems 
reasonable to hypothesize that prenatal exposure to VPA may indirectly influence 5-HT 
transmission, given the evidence for hyperserotonemia and altered serotoninergic neurons 
following prenatal VPA exposure – both of which are consistent with epidemiological 
studies of disrupted serotonergic systems in autistic populations (Anderson et al., 1987; 
Anderson, Horne, Chattergee, & Cohen, 1990; Cook et al., 1993; Betancur et al., 2002; 
Miyazaki, Narita, & Narita, 2005; Hadjikhani, 2010). Whatever the mechanism involved, 
the present findings of an increase in body shaking suggest that the VPA treatment was 
effective. 
Third, examination of the VPA-induced effects utilizing an oral dosing paradigm 
identical to the one used in the current study, revealed long-term behavioral and 
neuroanatomical alterations in rats that are consistent with symptoms of autism 
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(Mychasiuk et al., 2012; Raza et al., 2015). For instance, impaired performance was 
detected on several behavioral tasks – delayed non-match-to-sample T-maze, skilled 
reaching, elevated plus maze, and open field activity – offering interesting parallels to 
human autism literature, including compromised problem solving skills, delayed motor 
skill development, high levels of anxiety, and hyperactivity, respectively (McEvoy, 
Rogers, & Pennington, 1993; Bellini, 2004; Simonoff et al., 2008; Papadopoulous et al., 
2011). On an anatomical level, marked decreases in dendritic complexity of the medial 
prefrontal cortex (mPFC) and orbitofrontal (OFC) cortex were reported, consistent with 
substantial evidence of prefrontal cortex-dependent deficits in autism (Prior & Hoffman, 
1990; McEvoy et al., 1993). Thus, the studies conducted by Mychasiuk and colleagues 
(2012), and Raza and colleagues (2015) support the validity of the oral administration of 
VPA to pregnant dams as a means of inducing autistic-like anomalies in the developing 
offspring. Therefore, it is reasonable to conclude that the route of drug administration, in 
the present study, was similarly effective. 
Fourth, although the measures of play that reflect playful motivation were not 
altered by the VPA treatment, other measures that reflect how playful interactions are 
negotiated were changed. These changes may be indicative of the second DSM-IV 
diagnostic criterion for autism - impairment in social communication (American 
Psychiatric Association, 2013). During play fighting, rats maneuver so as to enhance 
body contact (Panksepp, 1981), which is highly rewarding (Panksepp, 1998). The VPA-
treated rats were less likely to use the complete rotation tactic, a tactic that promotes 
close body contact, and more likely to use defensive tactics involving remaining standing, 
tactics that block the partner’s access to the defender’s body (Pellis & Pellis, 1987; Pellis, 
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Pellis, & McKenna, 1994). Thus, while the rats may have been motivated to play, they 
limited the contact involved in playful wrestling. Again, this kind of ambivalence to 
playing with a social partner has been reported in autistic children, and may reflect 
deficits in their ability to engage in turn taking (Jordan, 2003). In addition to using 
maneuvers during play that promote reciprocal exchanges (Pellis et al., 2010), effective 
communication is essential to avoid the risk of escalation to serious fighting (Bekoff, 
1972, 1995). In rats, a likely source of signaling during play is the 50 kHz calls that are 
emitted during these interactions (Burgdorff et al., 2008; Brunelli et al., 2006; Himmler et 
al., 2014; Kisko et al., 2015; Knutson et al., 1998). The rate of calling per bout of play 
fighting was significantly reduced in the VPA-treated rats compared to controls. Indeed, 
contrary to what was found in previous studies (Knutson et al., 1998), and in the controls 
of the present study, the minute-by-minute analysis of the occurrence of play and the 
frequency of calling revealed that the frequency of vocalizing was at its lowest during the 
minutes when play was most frequent. This discordance between vocalizing and play, 
and the reduction in contact promoting tactics during play, may reflect altered socio-
communicative function, as well as dysregulation of pragmatics in social relations, both 
of which are thought to be characteristic of autism (Baron-Cohen, 1988). Irrespective of 
the mechanisms involved, these VPA-induced changes in play and vocalizing further 
support the interpretation that the VPA treatment was effective. 
The difference between the present study and the two previous ones reporting 
reductions of pinning during play (Schneider & Przewlocki, 2005; Chomiak et al., 2010) 
could be a matter of degree rather than one showing an effect on play and one not. First, 
the different routes of VPA administration may have resulted in a difference in the 
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dosage actually delivered to the fetuses. Given the use of intraperitoneal injections as the 
route of administration in the preceding two studies, it is plausible that oral 
administration of VPA, in the present study, may not have entered fetal circulation at the 
intended dose. It is difficult to estimate the proportion of VPA that crosses the placenta, 
given the variability in the metabolism and bioavailability of the VPA ingested by the 
dam (Favre et al., 2013; Raza et al., 2015). As such, it is likely that only a proportion of 
the total dosage entered fetal circulation, resulting in reduced toxicant exposure. 
Alternatively, the likelihood of fetal resorption may also account for the dampened 
behavioral impairments. As established by Vorhees (1987), the frequency of embryonic 
resorption is correlated with simultaneous increases in VPA dosage. It is plausible that in 
utero VPA exposure, at 800mg/kg (upper limit), may have induced a sample bias, in 
which only the embryos resistant to the VPA insult survived. Consequently, the number 
of viable offspring available for testing was reduced (Raza et al., 2015). 
Second, the kinds of changes characterized in play in the present study and the 
previous two have some similarity. During play fighting, the most common way for rats 
to end in the pin configuration is for the defender of a nape attack to rotate to supine 
(Pellis & Pellis, 1987). Thus, a reduction in the frequency of pinning could arise from a 
reduced frequency of playful attack or a reduced likelihood of using the rotation to supine 
tactic (S.M. Himmler, Lewis, & Pellis, 2014; Pellis et al., 1992). Thus, our findings that 
the VPA-treated rats were less likely to roll over to supine are consistent with the 
previous findings showing a reduction in pinning. In our case, the degree of VPA-
induced change may not have been sufficient to suppress the rotation to supine tactic 
sufficiently for this to be reflected in the pinning measure. Nonetheless, all these studies 
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point in the same direction of effect by the VPA. Thus, like previous studies, the present 
paper shows that in rats, early exposure to VPA induces changes in some aspects of 
sociality, aspects that mimic the situation in humans with autism. 
 
2.5.1. Conclusion 
The present study supports the validity that in utero exposure to VPA produces a 
viable rodent model for the study of autism. The changes in play, at least at the doses 
delivered in our method of administration, do not seem to affect the motivation to play, 
and so presumably the desire to socialize in general. However, the changes in how they 
play suggest that what rewards they may be gaining from play are altered. Like the 
broader distinction between 'wanting' and 'liking' in motivated behavior (Berridge, 1996; 
Berridge, Robinson, & Aldridge, 2009), dopaminergic systems are involved in rats 
seeking out the opportunity to play, but opioid systems are involved in rewarding the act 
of playing (Panksepp, 1998; Siviy, 1998; Siviy & Panksepp, 2011). The VPA-treated rats 
in the present study were just as motivated to engage in play, but the rewards offered by 
playing may be altered, hence reducing the pleasure to be gained from the physical 
contact usually associated with play (Vandershuren, 2010). This could account for the 
shift away from defense involving rotating to supine to defense involving keeping the 
partner at arms' length. Such a change may also explain the reduced rate of emitting 50-
kHz calls relative to the amount of play initiated, as higher rates of emission are 
associated with greater positive affect (Knutson, Burgdorf, & Panksepp, 2002).  
Alternatively, given the evidence that at least some of the 50-kHz calls may be 
used tactically to communicate with the partner during play (Himmler et al., 2014), the 
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reduced calling rate may reflect deficits in communication. Indeed, as negotiating close 
quarter contact, which occurs when one rat rolling over onto its back is attacked by 
another, appears to involve more sophisticated inter-animal coordination than other 
tactics not involved in such close-quarter action (Bell et al., 2009; Pellis & Pellis, 1987), 
a reduced ability to communicate could diminish the use of such tactics during play. 
Given the diversity of 50-kHz calls (Wright et al., 2010, Wright, Dodosiewiez, & Clarke, 
2012), a detailed analysis of the temporal structure of when different calls are emitted 
during the course of the moment-to-moment maneuvers performed during play may shed 
light on such deficits in communication. These communicatory effects of VPA need not 
be exclusive with the ones influencing the motivation and reward systems for social 
contact. As indicated by the present study and two previous ones (Schneider & 
Przewlocki, 2005; Chomiak et al., 2010), both may be compromised, depending on dose, 
and so mimic different facets of autism.  
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CHAPTER 3 
Tactile Stimulation Improves Neuroanatomical Pathology But Not Behaviour in 
Rats Prenatally Exposed to Valproic Acid∗  
 
3.1. Abstract 
Autism is a severe neurodevelopmental disorder with a population prevalence of 1 in 68, 
and dramatically increasing. While no single pharmacologic intervention has successfully 
targeted the core symptoms of autism, emerging evidence suggests that postnatal 
environmental manipulations may offer greater therapeutic efficacy. Massage therapy, or 
tactile stimulation (TS), early in life has repeatedly been shown to be an effective, low-
cost, therapeutic approach in ameliorating the cognitive, social, and emotional symptoms 
of autism. While early TS treatment attenuates many of the behavioral aberrations among 
children with autism, the neuroanatomical correlates driving such changes are unknown. 
The present study assessed the therapeutic effects of early TS treatment on behavior and 
neuroanatomy using the valproic acid (VPA) rodent model of autism. Rats were 
prenatally exposed to VPA on gestational day 12.5 and received TS shortly following 
birth. Whereas TS reversed almost all the VPA-induced alterations in neuroanatomy, it 
failed to do so behaviorally. The TS VPA animals, when compared to VPA animals, did 
not exhibit altered or improved behavior in the delayed non-match-to-sample T-maze, 
Whishaw tray reaching, activity box, or elevated plus maze tasks. Anatomically, 
                                                
∗Copyright © is maintained by author. Published as: Raza, S., Harker, A., Richards, S., 
Kolb, B., & Gibb, R. (2015). Tactile Stimulation Improves Neuroanatomical Pathology 
but not Behaviour in Rats Prenatally Exposed to Valproic Acid. Behavioural Brain 
Research, 282, 25-36. doi:10.1016/j.bbr.2014.12.055 
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however, there were significant increases in dendritic branching and spine density in the 
medial prefrontal cortex, orbital frontal cortex, and amygdala in VPA animals following 
early TS treatment, suggesting a complete reversal or remediation of the VPA-induced 
effects in these regions. The results suggest that postnatal TS, during a critical period in 
development, acts as a powerful reorganization tool that can ameliorate the 
neuroanatomical consequences of prenatal VPA exposure.  
 
3.2. Introduction 
Autism is a severe neurodevelopmental disorder that develops in the first 3 years 
of life. Characterized by impairments in social interactions, communication, and 
repetitive behaviors, the etiology of autism is not entirely known, but genetic and 
environmental components have been hypothesized to be involved (American Psychiatric 
Association, 1994; Schneider & Przewlocki, 2005). There is an accumulating body of 
evidence that in utero exposure to valproic acid (VPA), a teratogenic anticonvulsant, 
leads to an increased risk and incidence of autism (Bromley et al., 2009; Bath & 
Scharfman, 2013; Bromley et al., 2013). In fact, several retrospective human and case 
studies have documented difficulties in attentional, social, language, and motor abilities 
among children prenatally exposed to VPA, leading to the idea that valproate exposure 
during fetal development greatly alters neurodevelopment, including emotional and 
cognitive functioning (Christianson et al., 1994; Williams et al., 2001; Dean et al., 2002; 
Adab et al., 2004; Alsdorf & Wyszynski, 2005; Rasalam et al., 2005; Bromley et al., 
2009; Ornoy, 2009).  
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In view of the correlation between in utero VPA exposure and the incidence of 
autism in humans – a 4.42% absolute risk (Christensen et al., 2013) – the VPA rodent 
model of autism was developed (Rodier et al., 1996; Rasalam et al., 2005; Ornoy, 2009). 
Prenatal exposure to VPA on gestational day 12.5 has proven to be a viable rodent model 
of autism, as it appears to parallel the anatomical, functional, and behavioral pathology 
reported in human studies of autism (Mychasiuk et al., 2012). More specifically, rats 
prenatally exposed to VPA have been shown to exhibit structural and cellular features in 
brain similar to those observed in autistic patients, including physical malformations 
(Dufour-Rainfray et al., 2011), brainstem and cerebellar anomalies (Rodier et al., 1996; 
Rodier et al., 1997a), altered morphology of motor cortex neurons (Snow et al., 2008), 
and hyper-connectivity (Rinaldi et al., 2008). On a behavioral level, VPA rats have been 
shown to display many autistic-specific deficits, including decreased social interactions 
and behaviors, repetitive or stereotypic behaviors, low sensitivity to painful stimuli, and 
increased anxiety (Schneider & Przwelocki, 2005; Schneider et al., 2007; Bambini-Junior 
et al., 2011; Chomiak et al., 2013).  
In the US alone, autism is estimated to affect 1 in 68 children (Weintraub, 2011; 
Centers for Disease Control and Prevention, 2014) and is believed to be on the rise (Snow 
et al., 2008). In fact, rates are considerably higher than those 20 years ago (Fombonne, 
2002). Given the recent rise in the incidence of autism, the need for remedial and 
preventative strategies is crucial. Studies aimed at attenuating core autistic behavioral 
symptoms have primarily undertaken a pharmacological route (Buitelaar, 2003; 
Schneider et al., 2006). Although novel pharmacotherapies – such as risperidone and 
other atypical antipsychotics – have been central in managing related symptoms of 
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autism, treatment of the core symptoms remains a large area of unmet need (Wink, 
Erickson, & McDougle, 2010). As a result, intensive behavioral therapy has recently 
taken the forefront in numerous interventions targeted at autistic patients (Lovaas, 1987; 
Harris, Handleman, Gordon, Kristoff, & Fuentes, 1991; Ozonoff & Cathcart, 1998; 
Scheinkopf & Siegel, 1998; Josefi & Ryan, 2004; Lopata, Thomeer, Volker, & Nida, 
2006; Kim, Wigram, & Gold, 2008; Woo & Leon, 2013).  In fact, the efficacy of 
behavioral therapy is related to its positive lifelong implications (McEachin, Smith, & 
Lovaas, 1993). For instance, Fields et al. (1997) have demonstrated the positive influence 
of massage therapy among individuals with autism. Given twice a week for 20 min, 
massage therapy resulted in fewer stereotypical behaviors, reduced touch aversion, and 
greater social relatedness (in the classroom) among autistic children. Improvements in 
sleeping patterns, sensory impairments, and social and basic living skills have also been 
reported following massage therapy (Escalona et al., 2001; Cullen et al., 2005a; Hughes, 
2008). 
Massage therapy involves kinesthetic or sensory stimulation (Mathai, Fernandez, 
Mondkar, & Kanbur, 2001), an intervention equivalent to tactile stimulation (TS) in 
animal studies. Interestingly, animal studies have shown TS to be an effective measure of 
protection against cortical injury (Gibb, Gonzalez, Wegenast, & Kolb, 2010; Kolb & 
Gibb, 2010) and anxiety (Imanaka et al., 2008). TS has also been shown to stimulate 
maturation in preterm and newborn animals (Field et al., 1986; Schanberg & Field, 
1987), and even alter the behavioral and neuroanatomical organization in non-brain 
injured rats (Richards, Mychasiuk, Kolb, & Gibb, 2012). Given the abundance of 
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literature reinforcing TS as positive enriching experience, it is plausible that such an 
experience may offer preventative or remedial intervention in animal models of autism.  
The purpose of this study was to investigate the magnitude and extent, if any, of 
the behavioral and neuroanatomical changes induced by prenatal exposure to VPA and 
whether an early TS treatment can remediate such behavioral and anatomical pathologies. 
Using a within litter design, half of the rat pups derived from VPA and vehicle-treated 
dams were given TS treatment. To elucidate the therapeutic effects of TS on behavior in 
VPA animals, a battery of behavioral assessments were employed: delayed non-match-to-
sample T-maze, Whishaw tray reaching task, activity box, and elevated plus maze 
(EPM). The dendritic organization of the medial prefrontal cortex (mPFC; Cg3), 
orbitofrontal cortex (OFC; AID), and amygdala was quantified using Golgi methodology.  
 
3.3. Methods 
3.3.1. Subjects 
All experimental protocols were approved in accordance with the Canadian 
Council of Animal Care and the University of Lethbridge Animal Care Committee. 
Animals were born and raised in an accredited animal care facility at the University 
Lethbridge. Twelve dams and twelve male Long-Evans rats were utilized in this study. 
The control animals were a subset of a larger study conducted by Richards et al. (2012) 
and the same data was utilized. All procedures among the VPA and control animals – 
from gestation to adult behavioral testing – were identical and conducted during the same 
time period, to ensure no significant effect of time or any observable behavioral 
differences. A single male was paired with a single female in a shoebox cage and mating 
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behaviors were observed for 20 min. If mating behaviors were observed during this time 
interval, the male remained with the female over the next 24 hrs. If not, the male was 
removed. The breeding procedure was repeated the next morning and was continued until 
all male-female pairs were determined to have mated. Throughout the duration of the 
pregnancy, female rats were housed in pairs. However, upon the birth of rat pups, each 
mother was housed individually with her litter. The neonates remained with their mothers 
until weaning on postnatal day 21 (PN21), when they were, consequently, housed with 
their same-sex siblings. Eighty-two pups were born to 7 VPA dams (46 female, 36 male) 
and sixty-nine pups to 5 control dams (37 female, 32 male). Behavioral testing of pups 
commenced on PN65. Animals were housed in standard polycarbonate shoebox cages 
and maintained on a 12hr light/12hr dark diurnal cycle. Food and drinking water were 
available ad libitum, with the exception of food restriction during the duration of the 
Whishaw tray-reaching task. 
 
3.3.2. VPA Administration 
Pregnant dams were administered VPA on G12.5. Three days prior to VPA 
administration (G9-G11), all dams were given 1.5g/day of peanut butter. The peanut 
butter was spoon-fed to each individual rat. On G12.5, half of the dams were given 
peanut butter mixed with 800mg/kg of VPA, whereas the remaining control dams 
received peanut butter alone.  
  
3.3.3. Tactile Stimulation 
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Tactile stimulation (TS) was performed three times a day (09:00, 13:00, and 
16:00) for 15 min intervals. Seven VPA and five control litters were utilized, where equal 
numbers of male and female rat pups, within each litter, were randomly assigned to the 
tactile stimulation (TS) and non-tactile stimulation (NTS) groups. TS commenced on 
PN3 and continued until weaning. All animals were transported in their home cage to a 
testing room for the TS session. Dams were removed from the home cage and placed in a 
transport cage. The home cage, containing all the rat pups, was placed on a heating pad 
set to 24°C. During each session, a partition was used to separate the TS and NTS groups. 
A Swiffer® duster was used to stimulate the TS group. At the end of each session, 
mothers were returned to the home cage.  
 
3.3.4. Behavioral Methods 
3.3.4.1. Delayed Non-Match-to-Sample T-maze 
Testing on the non-match-to-sample T-maze task occurred between PN65 and 
PN75. For 10 consecutive days, ten trials were run per day. The task consisted of 2 trials, 
separated by a 10 sec delay. Trial 1 was a forced trial: one arm was blocked, whereas the 
other arm was open and contained a food reward. Trial 2 was a choice run: an animal had 
the choice of entering either arm (both arms were open), but the food reward was located 
in the arm opposite to that of trial 1. The open arm was randomly assigned and altered 
between trials. That is, a semi-random schedule was employed (for instance, day 1: 
RLRRLRLLRL; day 2: LRLLRLRRLR). The number of times the animal entered each 
arm on trial 2 was recorded and analyzed. When rats performed at 80% or better for 3 
consecutive days, training stopped.  
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3.3.4.2. Whishaw Tray Reaching Task 
Training and testing on the Whishaw tray-reaching task occurred successively 
from PN75 and PN95. Animals were food restricted (25g rat chow/day) on training days 
1 to 7 to encourage reaching behavior. It was ensured that the animals did not lose more 
than 10% of their pre-test body weight. Food restriction was increased slightly (that is, 
greater food deprivation; 20g rat chow/day) on days 8 to 21. The animals were placed in 
the reaching cages for 30 min per day. Following reaching and/or retrieval of the chicken 
pellets by the rats, pellets were consistently replaced to encourage further attempts. On 
test day (PN95), animals were video recorded for 5 min and, subsequently, the reaching 
behavior was scored. The attempted reaches, misses, and hits (that is, the successful 
reach, grasp, and consumption of food) were analyzed. A percent correct hit score 
(number of hits/total number of attempts) was determined. 
 
3.3.4.3. Activity Box 
On PN96, the exploratory behavior of the animals was recorded. Rats were 
individually placed in Accusan® activity-monitoring boxes. Each Plexiglas® box 
measured 41 X 41 X 30.5 cm, which recorded the movements of each rat. Rats were 
introduced to the activity box for 10 minutes and their activity level was recorded in two 
5-minute intervals, using the VersaMaxTM computer software.  The intervals were 
combined and the overall activity/distance travelled was determined. 
 
3.3.4.4. Elevated Plus Maze 
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 Testing on the EPM occurred approximately on PN105. The EPM apparatus 
consisted of 3 main components: a base (94 cm), two open arms (10 X 40 cm), and two 
closed arms (10 X 40 X 40 cm). The apparatus, made of black Plexiglas, was housed in a 
well-lit empty testing room. On testing day, rats were introduced to the maze, where their 
forepaws were placed in the center square of the maze facing a closed arm. Time spent in 
the open and closed arms were scored. An animal was deemed to be occupying an arm 
when the first half of their body entered the arm. Animals were video recorded for 5 
minutes, with the camera elevated at the end of an open arm. 
 
3.3.5. Anatomical Methods 
3.3.5.1. Histological Procedures 
Following behavioral testing, animals (~PN106) were administered an overdose 
of sodium pentobarbital and perfused with 0.9% saline. The brains were removed, 
weighed, and transferred to a Golgi-Cox solution for at least 14 days. Following 14 days 
of preservation in the Golgi-Cox solution, the brains were transferred to a 30% sucrose 
solution for at least 3 days. The brains were then sectioned on a Vibratome, at 200 µm, 
and mounted on gelatin-coated slides. Brains were stained following a protocol as 
described by Gibb and Kolb (1998).  
The dendritic architecture of pyramidal cells from layer III of the mPFC (Cg3) 
and OFC (AID), and amygdala were examined. Neurons, in each region of interest, were 
identified and traced at 250X with a camera lucida. It was ensured that the neuronal 
dendritic trees and branching were intact and not obscured by dendrites of other neurons, 
blood vessels, or astrocytes. Three measures were employed: 1) branch order (Cg3: apical 
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and basilar fields, AID: basilar), where the dendritic complexity was calculated by 
measuring the number of bifurcations from the cell body; 2) Sholl analysis (Cg3: apical 
and basilar fields, AID: basilar), where dendritic length was calculated using an overlay 
of concentric rings to count the number of intersections; and 3) spine density (Cg3: apical 
and basilar fields, AID: basilar; amygdala: basilar) to estimate the synaptic density along 
a dendritic segment based on the exact length and number of spines along that segment 
(spines/10µm). For each area of interest, 10 neurons (5 from each hemisphere) were 
analyzed using the three measures. An average value among the 5 neurons was calculated 
for each area in each hemisphere. 
 
3.3.6. Statistical Analyses 
 All statistical analyses were performed on SPSS 21 for Mac. Two-way ANOVAs 
with group (VPA or CON) and treatment (TS or NTS) as variables were performed to 
determine behavioral outcomes and any interactions. All neuroanatomical statistical 
analyses performed were three-way ANOVAs, to determine the interaction(s) among 
group (VPA or control), treatment (TS or NTS), and hemisphere (right or left) in each 
brain region. If an ANOVA did not reveal a significant effect of hemisphere, the data 
were collapsed. Sexes were analyzed independently for clarity of results description. The 
significance level was set at ≤ 0.05. All graphical representations of the data represent the 
means and standard error of measurement.  
 
3.4. Results 
3.4.1. Behavioral Results 
 
 
 
 
54 
3.4.1.1. Delayed Non-Match-to-Sample T-maze 
 VPA increased the days to criterion but there was no significant effect of TS 
treatment (Figure 3.1).  
 A two-way ANOVA of the days to reach criterion in the male group revealed a 
significant effect of group [F(1,24) = 4.462, p = 0.047], where VPA male animals took 
greater number of days to reach criterion compared to control counterparts. There was no 
effect of TS [F(1,24) = 3.790, p = 0.065] nor an interaction between Group and 
Treatment [F(1,24) = 0.139, p = 0.713].  
 A two-way ANOVA of the females revealed no main effect of group [F(1,25) = 
2.238, p = 0.149], treatment [F(1,25) = 0.131, p = 0.721], nor the interaction [F(1,25) = 
3.790, p = 0.064]. The interaction reflected a non-significant trend towards an increase in 
the number of days to reach criterion in the NTS VPA females, compared to NTS 
controls. Given that the data in Figure 3.1 appears to show a clear difference between the 
NTS groups in both sexes, we did a posthoc comparison of the NTS control and NTS 
VPA group, finding a significant difference [F(1,11) = 5.510, p = 0.041]. 
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3.4.1.2. Whishaw Tray Reaching Task 
 While VPA female animals exhibited significant motor impairments in retrieving 
food pellets when compared to control females, male animals were unaffected by prenatal 
VPA exposure. TS treatment did not influence performance on this task in either sex 
(Figure 3.2).  
A two-way ANOVA of percent hit score among the female group revealed a 
significant effect of group [F(1,78) = 5.011, p = 0.028], where VPA females exhibited 
impaired performance compared to controls. There was no significant effect of treatment 
[F(1,78) = 0.325, p = 0.570], nor an interaction between the Group and Treatment 
[F(1,78) = 1.993, p = 0.162].  
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Figure 3.1. Prenatal VPA exposure increased the number of days to reach 
criterion in the non-match-to-sample T-maze in NTS male, but not female, 
animals. Both sexes were unaffected by TS treatment.  
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In contrast to females, a two-way ANOVA for males revealed no main effect of 
group [F(1,57) = 0.890, p = 0.350], treatment [F(1,57) = 0.074, p = 0.787], nor an 
interaction [F(1,57) = 0.878, p = 0.353]. 
 
3.4.1.3. Activity Box 
 Prenatal VPA exposure increased the overall activity level in both sexes, although 
the effect of TS treatment was apparent only in female VPA animals. Male animals were 
unaffected by TS treatment (Table 3.1). 
 There was no significant effect of group [F(1,74) = 3.734, p = 0.057] or treatment 
[F(1,74) = 0.200, p = 0.656] for female animals. There was a significant interaction of 
Group and Treatment [F(1,74) = 4.650, p = 0.034], owing to higher activity among the 
TS VPA female animals (p = 0.004). Moreover, TS VPA females were significantly more 
active than NTS VPA females (p = 0.049).  
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Figure 3.2. Prenatal VPA exposure significantly decreased the percent hit 
score among female, but not male, animals in the Whishaw tray reaching 
task. Reaching performance in both sexes was unaffected by TS treatment. 
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 There was a significant group effect [F(1,55) = 9.804, p = 0.003] among male 
animals, as VPA increased activity. There was no effect of TS treatment [F(1,55) = 
0.547, p = 0.463] nor an interaction [F(1,55) = 0.008, p = 0.929] on locomotor activity. 
 
3.4.1.4. Elevated Plus Maze 
 In the EPM task, VPA female animals spent less time in the closed arms, but not 
open arms, compared to female controls. TS treatment had no effect among female 
animals. Males were unaffected by either VPA exposure or TS on this task (Table 3.1).  
 ANOVA of time spent in the closed arms by females revealed a main effect of 
group [F(1,83) = 7.474, p = 0.008], where control females spent greater time in the 
closed arms compared to VPA females. There was no effect of treatment [F(1,83) = 
0.001, p = 0.947] nor an interaction [F(1,83) = 1.014, p = 0.317] on closed arm time. 
ANOVA on time spent in the open arms, revealed no main effects of group [F(1,83) = 
0.788, p = 0.377], treatment [F(1,83) = 0.064, p = 0.801], nor an interaction [F(1,83) = 
0.258, p = 0.613]. 
 ANOVA on the time spent in the closed arms in the male group revealed no 
significant effect of group [F(1,61) = 0.700, p = 0.406], treatment [F(1,61) = 0.284, p = 
0.596], nor an interaction [F(1,61) = 0.407, p = 0.526]. Time spent in the open arms 
revealed a similar trend among males animals: no significant effect of group [F(1,61) = 
0.274, p = 0.602], treatment [F(1,61) = 0.104, p = 0.748], nor an interaction [F(1,61) = 
0.783, p = 0.380]. 
 
3.4.2. Summary of Behavioral Results  
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The behavioral results are summarized in Table 3.1. The VPA-treated rats 
exhibited significant behavioral changes (or, in some cases, significant interactions) on an 
adult battery of behavioral tests. Whereas impaired behavior was observed among female 
VPA animals on all tasks, behavioral alterations among VPA males were exhibited only 
on the T-maze and activity box tasks. Compared with the control group, VPA-treated rats 
demonstrated: (1) impaired performance on the delayed non-match-to-sample T-maze; 
(2) motor dysfunction on the Whishaw tray reaching task; (3) hyperactive locomotor 
behavior; and (4) reduced propensity to remain in the closed arms of the EPM, suggesting 
altered anxiety. Surprisingly, early TS treatment did not alter behavior on any task, with 
the exception of the increased activity in female VPA animals in the activity box.  
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Table 3.1. Main effects of VPA and TS treatment from two-way ANOVAs for all 
behavioral tasks measured. Sexes were analyzed independently. 
Behavioural Task 
VPA TS 
Male Female Male  Female 
T-Maze 
 
	  	  
	  
	  	  
 
Days to Criterion é é+ -­‐	   -­‐	  
  	  
	  	  
	  
	  	  
Tray Reaching 
	  
	  	  
	  
	  	  
 
% Hits -­‐	   ê -­‐	   -­‐	  
  	  
	  	  
	  
	  	  
Activity Box 
	  
	  	  
	  
	  	  
 
Activity Level é é+ -­‐	   é+ 
  	  
	  	  
	  
	  	  
EPM 
	  
	  	  
	  
	  	  
 
Time Spent in Closed Arms -­‐	   ê -­‐	   -­‐	  
  Time Spent in Open Arms -­‐	   -­‐	   -­‐	   -­‐	  
+, Trend towards significance or significant interaction 
 
3.4.3. Anatomical Results 
3.4.3.1. Medial Prefrontal Cortex (Cg3) 
3.4.3.1.1. Dendritic Branching 
Apical. The apical dendritic branching of pyramidal cells in the mPFC was 
reduced in VPA female and male animals, compared to controls. In contrast, TS 
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treatment increased apical dendritic branching in all groups, suggesting a remediating 
effect of the TS treatment in the VPA group (Figure 3.3A).  
Female animals demonstrated main effects of group [F(1,75) = 4.623, p = 0.035] 
and treatment [F(1,75) = 53.232, p ≤ 0.001] but no interaction [F(1,75) = 1.836, p = 
0.180]. Thus, whereas VPA decreased branching, TS treatment increased it in all groups. 
ANOVA in males showed a significant effect of treatment [F(1,59) = 8.973, p = 
0.004], where TS increased apical dendritic branching, but there was no main effect of 
group [F(1,59) = 2.865, p = 0.096]. There was a significant interaction [F(1,59) = 13.208, 
p = 0.001], demonstrating that NTS VPA males exhibited reduced apical dendritic 
branching (p = 0.001) relative to NTS controls. In addition, TS VPA males exhibited 
greater apical dendritic branching compared to NTS VPA counterparts (p ≤ 0.001). 
Basilar. TS treatment increased the basilar dendritic branching of pyramidal cells 
in the mPFC in both sexes. In addition, both female and male animals exhibited greater 
dendritic branching in the right hemisphere, as opposed to the left. VPA only decreased 
basilar dendritic branching in males and this effect was remediated by TS treatment. 
 A three-way ANOVA (Group X Treatment X Hemisphere) of basilar dendritic 
branching among female animals demonstrated a significant effect of treatment [F(1,75) 
= 28.932, p ≤ 0.001] and hemisphere [F(1,75) = 13.743, p ≤ 0.001], but no main effect of 
group [F(1,75) = 0.624, p = 0.432]. TS treatment significantly increased basilar dendritic 
branching compared to NTS females. Greater basilar dendritic branching was also 
observed in the right hemisphere, as opposed to the left. The basilar dendritic branching 
in the right hemisphere for both VPA females (p = 0.002) and control females (p = 0.039) 
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was greater than the left hemisphere. There was no Group X Treatment X Hemisphere 
interaction [F(1,75) = 0.152, p = 0.698] (Figure 3.3B). 
When subjected to a three-way ANOVA (Group X Treatment X Hemisphere), 
basilar dendritic branching among male animals revealed a main effect of group [F(1,59) 
= 3.847, p = 0.05], treatment [F(1,59) = 20.002, p ≤ 0.001], and hemisphere [F(1,59) = 
4.393, p = 0.041]. While VPA decreased basilar dendritic branching along males (p = 
0.05), it appeared that TS treatment produced an increase in basilar dendritic branching 
compared to NTS counterparts in both sexes (p ≤ 0.001). In addition, the right 
hemisphere exhibited an increase in basilar dendritic branching compared to the left 
hemisphere (p = 0.041). A two-way interaction between Group and Treatment [F(1,59) = 
8.562, p = 0.005] was also observed, where branching in right hemisphere of NTS control 
(p ≤ 0.001) and TS VPA (p ≤ 0.001) males was greater than branching in NTS VPA 
males of the same hemisphere. This effect was also observed in the left hemisphere of TS 
VPA animals (p = ≤ 0.001). There was no three-way interaction (Group X Treatment X 
Hemisphere) [F(1,59) = 0.133, p = 0.717] (Figure 3.3C). 
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Figure 3.3. Changes in dendritic branching of pyramidal cells in Cg3 in response to 
prenatal exposure to VPA and TS. (A) Dendritic branching of apical dendrites. VPA 
significantly reduced apical dendritic branching of both sexes. This effect was 
remediated by TS treatment. (B) Dendritic branching of basilar dendrites in female 
animals. TS increased basilar dendritic branching in female animals. Greater basilar 
dendritic branching was observed in the right hemisphere, as opposed to the left. 
Branching was unaffected by VPA. (C) Dendritic branching of basilar dendrites in 
male animals. While VPA decreased Cg3 basilar dendritic branching in males, this 
effect was remediated by TS treatment. Greater basilar dendritic branching was 
observed in the right hemisphere, as opposed to the left.  
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3.4.3.1.2. Dendritic Length 
Apical. TS treatment significantly increased the apical dendritic length of all 
groups, female and male, compared to the NTS counterparts. TS treatment appeared to 
block the effect of VPA and increase the apical dendritic length in both female and male 
cohorts (Figure 3.4A). 
A two-way ANOVA of the apical dendritic length in female animals revealed a 
main effect of treatment [F(1,119) = 90.617, p ≤ 0.001], but not of group [F(1,119) = 
3.662, p = 0.058] nor the interaction [F(1,119) = 0.008, p = 0.928]. Thus, TS treatment 
significantly increased apical dendritic length among all female groups. Prenatal VPA 
exposure produced a trend towards a reduction in dendritic length.  
ANOVA on male animals revealed a main effect of treatment [F(1,81) = 60.173, 
p ≤ 0.001] and a significant interaction [F(1,81) = 7.953, p = 0.006], but no effect of 
group [F(1,81) = 3.412, p = 0.069]. More specifically, the apical dendritic length in NTS 
VPA males was reduced compared to NTS controls (p = 0.004). This was reversed by 
TS, as TS VPA males exhibited an increase in apical dendritic length when compared to 
NTS VPA counterparts (p ≤ 0.001), a TS result that was also observed among TS 
controls (p = 0.002).  
Basilar. The basilar dendritic length of pyramidal cells in the mPFC was reduced 
in VPA animals, whereas TS treatment increased basilar dendritic length in all groups. 
The length of cells in the right hemisphere was significantly longer than those in the left 
hemisphere.  
ANOVA on the basilar dendritic length in the Cg3 region of female animals 
revealed a significant effect of treatment [F(1,114) = 66.000, p ≤ 0.001] and hemisphere 
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[F(1,114) = 15.798, p ≤ 0.001], where TS treatment significantly increased basilar 
dendritic length. Basilar dendritic branching was also greater in the right hemisphere. 
There was a non-significant trend for an effect of group [F(1,114) = 3.253, p = 0.074], 
where prenatal exposure to VPA decreased Cg3 basilar dendritic length. There was no 
significant interaction [F(1,114) = 0.335, p = 0.564] (Figure 3.4B). 
ANOVA of basilar dendritic length in males revealed a main effect of group 
[F(1,81) = 6.271, p = 0.014], treatment [F(1,81) = 27.148, p ≤ 0.001], and hemisphere 
[F(1,81) = 6.579, p = 0.012]. VPA males exhibited decreased basilar dendritic length 
compared to control males (p = 0.014), whereas TS-treated males had greater basilar 
dendritic length (p ≤ 0.001). Interestingly, the right hemisphere exhibited significantly 
greater basilar dendritic length than that of the left hemisphere (p = 0.012). A significant 
two-way interaction between Group and Treatment was revealed [F(1,81) = 5.166, p = 
0.026], where the basilar dendritic length in the right hemisphere of NTS VPA males was 
reduced compared to the NTS control males of the same hemisphere (p = 0.046). The 
same effect was observed in the left hemisphere (p = 0.023). In addition, VPA males that 
underwent TS treatment displayed increased basilar dendritic length in the right (p ≤ 
0.001) and left (p ≤ 0.001) hemispheres compared to the NTS VPA males. There was no 
Group X Treatment X Hemisphere interaction [F(1,81) = 0.073, p = 0.788] (Figure 3.4C). 
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Figure 3.4. Changes in dendritic length of pyramidal cells in Cg3 in response to 
prenatal exposure to VPA and TS. (A) Dendritic length of apical dendrites. TS 
treatment significantly increased apical dendritic length of both sexes, blocking the 
VPA-induced reduction in length. (B) Dendritic length of basilar dendrites in 
female animals. TS treatment significantly increased basilar dendritic branching, 
remediating the VPA-induced trend of decreased dendritic length. The length of 
cells in the right hemisphere was significantly longer than those in the left 
hemisphere. (C) Dendritic branching of basilar dendrites in male animals. VPA 
significantly reduced basilar dendritic length, whereas TS treatment significantly 
increased length. The length of cells in the right hemisphere was significantly 
longer than those in the left hemisphere.  
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3.4.3.1.3. Spine Density 
Apical. Prenatal exposure to VPA significantly reduced the apical spine density of 
Cg3 pyramidal cells among male animals. TS treatment, on the other hand, significantly 
increased apical spine density in both sexes, irrespective of group. In fact, among VPA 
female and male animals, it appears that TS treatment may have remediated or blocked 
the VPA-induced changes in the apical spine density in both sexes (Figure 3.5A). 
 A two-way ANOVA of the apical spine density among female animal revealed a 
main effect of treatment [F(1,119) = 36.400, p ≤ 0.001], but no main effect of group 
[F(1,119) = 0.033, p = 0.857] or interaction [F(1,119) = 3.312, p = 0.071] of both groups. 
In males, there was a main effect of group [F(1,83) = 9.458, p = 0.003] and 
treatment [F(1,83) = 20.055, p ≤ 0.001], as well as an interaction [F(1,83) = 7.319, p = 
0.008]. The interaction reflected the fact that TS increased spine density in the VPA-
treated group, but not in the controls. In fact, the TS treatment in VPA animals raised the 
spine density to control levels. 
Basilar. The basilar spine density of pyramidal cells of the mPFC was 
significantly increased in VPA female and male animals following TS treatment. Basilar 
spine density was decreased as a result of prenatal VPA exposure, which was more 
pronounced in males, but TS treatment remediated the prenatal drug-induce decrease in 
basilar spine density (Figure 3.5B). 
 ANOVA on the spine density for female animals revealed no significant effect of 
group [F(1,119) = 0.825, p = 0.366], but a main effect of treatment [F(1,119) = 91.011, p 
≤ 0.001] and a significant two-way interaction [F(1,119) = 15.649, p ≤ 0.001]. Both 
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control and VPA groups showed increased spine density after TS, the effect being larger 
in the VPA group. 
ANOVA on the spine density for males revealed a main effect of group [F(1,83) 
= 16.123, p ≤ 0.001], treatment [F(1,83) = 29.395, p ≤ 0.001], and an interaction [F(1,83) 
= 19.767, p ≤ 0.001]. As with the apical spines, the interaction reflected the fact that the 
TS treatment increased spine density in the VPA-treated group but not in the controls. 
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Figure 3.5. Changes in spine density of pyramidal cells in Cg3 in response to 
prenatal exposure to VPA and TS. (A) Spine density on segment of apical 
dendrites. Prenatal exposure to VPA significantly reduced the apical spine density 
of male animals. Females were unaffected by prenatal VPA exposure. TS treatment 
significantly increased apical spine density in VPA males and female groups. (B) 
Spine density on segment of basilar dendrites. The basilar spine density of males 
was significantly reduced in response to prenatal VPA exposure. TS treatment 
significantly increased basilar spine density in both sexes, which was more 
pronounced in the VPA groups.  
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3.4.3.2. Orbital Prefrontal Cortex (AID) 
3.4.3.2.1. Dendritic Branching 
VPA reduced branching in male animals, but TS increased branching in the VPA-
treated rats and the female controls (Figure 3.6). 
A two-way ANOVA of dendritic branching in females revealed a main effect of 
treatment [F(1,115) = 47.681, p ≤ 0.001], but no effect of group [F(1,115) = 0.546, p = 
0.462], nor an interaction [F(1,115) = 1.361, p = 0.246]. TS treatment significantly 
increased dendritic branching of AID pyramidal cells in both VPA and control groups.  
A two-way ANOVA of dendritic branching in males revealed a main effect of 
group [F(1,79) = 10.040, p = 0.002], treatment [F(1,79) = 28.725, p ≤ 0.001], and an 
interaction [F(1,79) = 32.694, p ≤ 0.001]. The interaction resulted from the large group-
specific effect of TS. In fact, TS increased the dendritic branching in the VPA animals 
above control levels.  
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3.4.3.2.2. Dendritic Length 
VPA did not significantly reduce dendritic length in either sex. TS treatment 
increased dendritic length in the male VPA and both female groups (Figure 3.7). 
A two-way ANOVA of dendritic length in females revealed a significant effect of 
treatment [F(1,121) = 83.432, p ≤ 0.001] and the interaction [F(1,121) = 9.301, p = 
0.003], but there was no main effect of group [F(1,121) = 1.093, p = 0.298]. The 
interaction reflected a trend towards a VPA-induced effect and a larger TS effect in the 
VPA group than the control groups. 
A two-way ANOVA of dendritic length in the male group revealed a significant 
effect of treatment [F(1,79) = 19.855, p ≤ 0.001] and the interaction [F(1, 79) = 14.728, p 
≤ 0.001], but no main effect of group [F(1,79) = 2.657, p = 0.107]. The interaction 
reflected the group-specific effects of TS shown in Figure 3.7. 
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Figure 3.6. VPA reduced dendritic branching in the AID region of 
male, but not female animals. TS treatment significantly increased 
branching in the VPA-treated animals and female groups. 
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3.4.3.2.3. Spine Density 
While prenatal exposure to VPA did not alter spine density in females, TS 
treatment significantly decreased spine density in the control group, but not in the VPA 
group. In contrast to females, VPA induced a reduction in spine density in males. While 
TS treatment produced a trend towards an increase in spine density among male animals, 
this effect was most prominent among VPA males, where TS treatment reversed the 
effects of VPA (Figure 3.8). 
A two-way ANOVA of spine density in females revealed a main effect of 
treatment [F(1,107) = 5.683, p = 0.0019] and the interaction [F(1,107) = 14.229, p ≤ 
0.001], but no effect of group [F(1,107) = 0.940, p = 0.334]. In this case, the interaction 
demonstrated that there was no effect of VPA and that TS treatment actually decreased 
spine density in the control animals (p ≤ 0.001), but did not affect the VPA group. 
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Figure 3.7. Prenatal exposure to VPA decreased dendritic length in the 
AID region of NTS male and female animals. Interestingly, early TS 
treatment increased dendritic length in male VPA and female groups.  
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ANOVA on the male animals revealed a significant effect of group [F(1,81) = 
24.806, p ≤ 0.001] and the interaction [F(1,81) = 11.362, p = 0.001], but no effect of 
treatment [F(1,81) = 3.239, p = 0.0076]. The interaction reflected the fact that TS only 
increased spine density in the VPA group (p ≤ 0.001). 
 
3.4.3.3. Amygdala 
3.4.3.3.1. Spine Density 
The effect of VPA was exhibited only among female animals, where prenatal 
VPA exposure increased amygdalar spine density. TS treatment, on the other hand, 
stimulated an increase in amygdalar spine density among all animals (Figure 3.9). 
A two way ANOVA on females revealed a significant effect of group [F (1,125) 
= 9.718, p = 0.002] and treatment [F (1,125) = 122.121, p ≤ 0.001], but no interaction [F 
0 
2 
4 
6 
8 
10 
12 
Control VPA Control VPA 
Male Female 
Sp
in
es
 / 
10
µm
 
TS 
NTS 
Figure 3.8. AID spine density was significantly reduced in males, but 
not females, following prenatal VPA exposure. While TS decreased 
spine density in female controls, an increase in density was observed in 
the male VPA group.  
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(1,125) = 1.311, p = 0.254]. More specifically, amygdalar spine density was shown to 
increase (independently) in response to VPA, as well TS treatment. 
In contrast, ANOVA on males revealed a significant effect of TS treatment 
[F(1,92) = 50.266, p ≤ 0.001], but not for group [F(1,92) = 1.600, p = 0.209] or the 
interaction [F(1,92) = 0.302, p = 0.584]. 
 
3.4.4. Brain Weight 
Statistical analyses of adult brain weight revealed a significant reduction in brain 
weight in VPA females, but not VPA males. There was no effect of TS on brain weight. 
A two-way ANOVA of female brain weight revealed a main effect of group 
[F(1,81) = 3.796, p = 0.055], but no significant effect of treatment [F(1,81) = 1.235, p = 
0.270], nor an interaction [F(1,81) = 1.503, p = 0.224]. 
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Figure 3.9. Prenatal exposure to VPA significantly increased amygdalar 
spine density among female animals, but not males. TS treatment 
significantly increased amygdalar spine density in both sexes. 
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A two-way ANOVA for males found no significant effect of group [F(1,65) = 
3.047, p = 0.086], treatment [F(1,65) = 0.025, p = 0.874], nor an interaction [F(1,65) = 
0.000, p = 0.992].  
  
3.4.5. Body Weight 
Prenatal VPA exposure significantly increased body weight among female VPA 
animals. TS treatment increased body weights among VPA, but not control, females. 
Male body weight was unaffected by either prenatal VPA exposure or TS treatment.  
A two-way ANOVA of female body weight revealed a significant effect of group 
[F(1,81) = 7.216, p = 0.009] and the interaction [F (1,81) = 5.258, p = 0.025], but no 
effect of TS treatment [F(1,81) = 0.237, p = 0.627]. The interaction reflected the fact that 
TS increased body weight among VPA females (p ≤ 0.001). 
A two-way ANOVA of male body weight revealed no significant effects of group 
[F(1,65) = 0.266, p = 0.608], treatment [F(1,65) = 0.450, p = 0.505], nor an interaction 
[F(1,65) = 0.002, p = 0.966]. 
 
3.4.6. Summary of Neuroanatomical Results 
The anatomical results are summarized in Table 3.2. Analysis of neuroanatomical 
measures indicates that early TS treatment reversed almost all VPA-induced changes in 
dendritic morphology in male and female animals. Among the three brain regions 
examined – Cg3, AID, and amygdala – 10 measurements (dendritic complexity, dendritic 
length, and spine density) per sex were analyzed. Among female animals, 2 measures 
were significantly affected by prenatal VPA exposure, while 6 measures exhibited an 
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interaction or trend towards significance. For male animals, 6 measures were 
significantly altered in response to VPA and 3 measures demonstrated a significant 
interaction. Only female brain and body weight was altered in response to prenatal VPA 
exposure. Early TS treatment significantly reversed all changes in dendritic morphology 
in VPA animals. More specifically, TS increased dendritic complexity, length, and spine 
density in all male and female animals (with the exception of AID spine density) in all 
brain regions. Although TS did not alter brain weight, an increase in body weight was 
observed among VPA female animals.    
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Table 3.2. Main effects of VPA and TS treatment from three-way ANOVAs for all 
neuroanatomical measurements examined. Sexes were analyzed independently. 
Anatomical Measurement 
VPA TS 
Male Female Male Female 
Branch Order 
    
 
Cg3 apical ê+ ê é é 
 
Cg3 basilar ê - é é 
 
AID ê - é é 
      Sholl 
    
 
Cg3 apical ê+ ê+ é é 
 
Cg3 basilar ê ê+ é é 
 
AID ê+ ê+ é é 
      Spines 
    
 
Cg3 apical ê - é é 
 
Cg3 basilar ê ê+ é é 
 
AID ê ê+ é+ ê 
 
Amygdala - é é é 
+, Trend towards significance or significant interaction 
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3.5. Discussion 
The findings of the current study are in concordance with previous reports that 
prenatal exposure to VPA on gestational day 12.5 produces long-term selective effects on 
behavior and neuroanatomy in male and female rats (Schneider & Przewlocki, 2005; 
Schneider et al., 2007; Mychasiuk et al., 2012). The therapeutic effects of early TS 
treatment were detected in the anatomical pathology of rats prenatally exposed to VPA, 
completely reversing the effects of VPA in the regions measured. Surprisingly, however, 
TS treatment failed to remediate or alter behavior in VPA animals.  
 
3.5.1. Effects of VPA and early TS on behavioral outcomes   
 Prenatal exposure to VPA altered behavior among animals. Consistent with the 
findings of Mychasiuk and colleagues (Mychasiuk et al., 2012), VPA-treated animals 
exhibited impaired performance on the delayed non-match-to-sample T-maze, Whishaw 
tray reaching, and EPM tasks. With respect to activity level, increased activity or 
hyperactivity was demonstrated among male and female VPA animals. Interestingly, 
however, VPA female animals exhibited alterations in behavior on all tasks, whereas 
behavioral changes among VPA-treated males were evident only on the T-maze and 
activity box tasks. Given that autism occurs predominately in males – a 4 to 1 
male/female ratio – the behavioral differences among the sexes in the current study were 
surprising (Currenti, 2010; Rubenstein & Merzenich, 2003). Although impairments in 
behavior among VPA animals were detected on a multitude of tasks, the magnitude of 
such impairments were not as robust as anticipated. While prenatal exposure to VPA did 
alter behavior, the effects were sex-dependent and varied depending on the measures 
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scored. Given that the bioavailability, metabolism, and pharmacokinetics of in utero VPA 
exposure vary among rodents (Favre et al., 2013), it is difficult to estimate the proportion 
or level of VPA that enters fetal circulation to induce autistic-like abnormalities. While 
the current literature does demonstrate that in utero VPA exposure at higher doses (upper 
limit of 800mg/kg) is sufficient to produce autistic-like anomalies in rodents (Vorhees, 
1987), the bulk of such studies utilize intraperitoneal injections as the route of 
administration. As such, in the current study, it is plausible that the oral dose of VPA 
administered, 800mg/kg, may not have entered fetal circulation in entirety, therefore 
dampening toxicant exposure. Alternatively, it is also quite plausible that the 800mg/kg 
dose of VPA induced a sample bias through embryonic resorption. Vorhees (1987) has 
previously established a dose-dependent relationship for resorption rate and fetal outcome 
following prenatal VPA exposure, where the frequency of fetal resorption increases – in a 
step-wise fashion – with excessive doses of VPA. In the current study, we may 
hypothesize that perhaps only a subset of the embryos survived the VPA insult given the 
large dose. It is plausible that only the embryos resistant to the VPA insult survived, 
reducing the number of viable offspring for behavioral testing. Consequently, the 
magnitude of the observed behavioral impairments may not have been robust or severe as 
originally anticipated. As a result, establishing a precise oral dose threshold to produce 
specific autistic-like features may prove to be useful to control for in utero VPA exposure 
in future studies. 
Contrary to expectation, early TS treatment did not significantly alter behavior on 
the majority of tasks. Surprisingly, no significant differences among TS and NTS 
animals, irrespective of prenatal VPA exposure or sex, were observed. While early TS 
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treatment does, indeed, induce neuroplastic changes among animals – VPA and control – 
it may be the case that the behavioral tasks employed were not sensitive enough to detect 
TS-related modifications to behavior. More specifically, many of the behavioral tasks 
utilized have been designed to highlight deficits in animal models of brain damage (Kolb 
& Gibb, 1990; Kolb, Cioe, & Whishaw, 2000; Kolb & Gibb, 2007), rather than 
therapeutic effects, so it may be the case that the protocols utilized are not sensitive to the 
more subtle effects of TS. As previously mentioned, it is likely that the behavioral 
deficits produced by prenatal VPA exposure are mild, especially when compared to the 
deficits produced in lesions studies; as such, TS-induced changes in behavior among 
VPA animals may not be large enough to be detected. The lack of TS induced 
modification to behavior among all animals is further supported by the study conducted 
by Richards and colleagues (2012) where early TS treatment failed to alter normal adult 
rat behavior on the Whishaw tray reaching, EPM, and activity box tasks. While dendritic 
reorganization in the prefrontal cortex (PFC) and amygdala were demonstrated following 
early TS treatment, alterations in behavior were not exhibited. This further supports that 
idea that the therapeutic effects of TS escape detection on such behavioral tasks and 
future studies may need to rethink how to demonstrate this.  
 Although a heterogeneous neurodevelopmental disorder, autism is characterized 
principally by impaired social interactions. Impairments in reciprocal interactions, 
emotional recognition, and expressions are commonly manifested during peer-play 
among individuals with autism (American Psychiatric Association, 1994; Volkmar, 
Carter, Grossman, & Klin, 1997). Given that early social play is imperative to the proper 
development of social competency and emotional regulation in humans (Pellis & Pellis, 
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2009), a rat model of peer play may prove to be an ideal system to better understand the 
etiology of autism. In fact, Schneider & Przewlocki (2005) have demonstrated attenuated 
social play among VPA rats in juvenile and adulthood, suggesting an inability to express 
intraspecific communicative signals, as well as inadequate performance of social 
behaviors. Given the validity of the VPA rodent model of autism in detecting 
disturbances in social play behavior, investigation into the efficacy of early therapeutic 
treatments in attenuation or reversal of these social impairments may offer a new avenue 
for research. More specifically, investigating the enriching effects of early TS treatment 
on social play behavior in the VPA model of autism may prove to be a more sensitive 
measure of the therapeutic effects of such a treatment. In fact, high levels of maternal 
licking and grooming – a form of TS – have been shown to alter play fighting in 
periadolescent rats, suggesting profound alterations in the development of sociality and 
competency (Parent & Meaney, 2008). As such, social play may serve as a good model 
for exploring the therapeutic effects of TS in the VPA rodent model of autism.  
 
3.5.2. Effects of VPA and early TS on dendritic morphology 
Despite the lack of change in behavior, there were significant neuroanatomical 
changes induced by both prenatal VPA exposure and early TS treatment. Consistent with 
the findings of Mychasiuk and colleagues (2012), prenatal VPA exposure significantly 
altered the neuronal morphology of the PFC, reducing dendritic branching, length, and 
spine density in the mPFC and OFC. A significant increase in amygdalar spine density 
was also exhibited among female VPA animals. Remarkably, however, early TS 
treatment reversed all neuroanatomical alterations induced by prenatal VPA exposure, 
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completely remediating the effects of VPA alone. More specifically, a general increase in 
dendritic complexity, length, and synaptic contact was observed in all cortical areas (with 
the exception of spine density in the OFC of females) and the amygdala, resulting in 
anatomical morphology comparable to that of control animals. Given the abundance of 
literature demonstrating the permanent and widespread effects of early TS treatment on 
the morphological and neurochemical structures in the cortex of normal and brain-injured 
animals (Schanberg & Field, 1987; Kolb et al., 2000; Gibb et al., 2010; Kolb & Gibb, 
2010; Kolb, Mychasiuk, Williams, & Gibb, 2011), it is no surprise that the autistic brain 
is susceptible to such changes in response to early enriching experiences. It has been well 
established that the developing brain is a highly plastic and malleable structure, capable 
of restructuring neuronal circuits in response to environmental influences, especially 
during critical periods (Greenough, Black, & Wallace, 1987; LeBlanc & Fagiolini, 2011). 
Given that TS treatment, in the current study, encompassed these sensitive periods of 
development, it is likely that changes in neural circuitry will emerge. Even more, in 
autism, it has been hypothesized that the expression and/or timing of critical periods in 
several brain regions are disrupted early in development, also resulting in altered 
plasticity and miswired circuits that are unable to respond optimally to future experiences 
(LeBlanc & Fagiolini, 2011). Taken together, it is apparent that both prenatal VPA 
exposure and early TS treatment differentially affect brain plasticity during development. 
Although the precise mechanism of the additive effect of both experiences is not yet 
known, we may postulate that postnatal TS is perhaps recreating plasticity in the VPA 
brain, recovering proper function – at least in the case of the brain regions measured here. 
It is possible, of course, that other brain regions were altered by the VPA treatment and 
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these regions were not normalized by the TS, which could account for the lack of 
behavioral effects of the TS.   
Our finding of greater dendritic branching and length in the right hemisphere of 
the basilar dendrites in Cg3 is consistent with an earlier report that T-maze training 
produces increased length in the right hemisphere in both Cg3 and Par1 (Comeau, 
McDonald, & Kolb, 2010). This result does not result from spatial maze training in 
general, however, as training rats in a spatial reversal task or the Morris water task did 
not produce this asymmetrical result (Kolb, Cioe, & Comeau, 2008; Comeau et al., 
2010). Perhaps it is the working memory aspect of the T-maze training that is critical. 
 
3.5.3. Potential underlying mechanisms  
 In elucidating the attenuating neuroanatomical effects of early TS treatment in 
VPA animals, potential underlying cellular and molecular mechanisms should be 
considered. It has been well established that balanced cortical excitatory and inhibitory 
(E/I) neurotransmission is crucial in the developing brain, given the tight regulation of 
critical periods. Central to the establishment of this homeostatic E/I transmission is the 
GABAergic system, wherein γ-aminobutyric acid (GABA) – an inhibitory 
neurotransmitter that also has excitatory effects in the developing brain – plays an 
important role in the maturation of inhibitory circuits and the establishment of neuronal 
connectivity (Manent et al., 2005; Represa & Ben-Ari, 2005; Wang & Kriegstein, 2008; 
LeBlanc & Fagiolini, 2011; Kilb, Kirischuk, & Luhmann, 2013). GABA is imperative to 
brain development, as it influences a wide range of processes including neurogenesis, 
neurite growth and axon elongation, neuronal migration, and synaptic connectivity (Kilb, 
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2012; Kilb et al., 2013). GABA is also known to regulate the expression of GABAA 
receptor subunits and down-regulate GABA receptor binding (Tehrani & Barnes, 1988; 
Hablitz, Tehrani, & Barnes, 1989; Schousboe & Redburn, 1995). As previously 
mentioned, an imbalance in the E/I transmission may cause, in some cases, excessive 
plasticity or in other cases, insufficient plasticity. With respect to altered critical period 
plasticity in the autistic brain, it has been demonstrated that cortical E/I 
neurotransmission is greatly disrupted and is likely contributing to the anomalies in 
behavior and neural circuitry (Rubenstein & Merzenich, 2003; LeBlanc & Fagiolini, 
2011). More specifically, it has been hypothesized that this E/I imbalance may be related 
to suppression in GABAergic signaling, leading to a reduction in inhibition and 
alterations in cortical circuitry (Hussman, 2001; Rubenstein & Merzenich, 2003). In fact, 
human studies have, indeed, demonstrated decreased GABA levels in the frontal lobe of 
autistic patients (Harada et al., 2011), reduction in protein levels of enzymes that 
synthesize GABA in the cerebellar and parietal cortices (Fatemi et al., 2002), and down-
regulation of GABAA receptors in the superior frontal cortex, parietal cortex, and 
cerebellum (Fatemi, Reutiman, Folsom, & Thuras, 2009). A reduction in GABA receptor 
binding can severely impair brain development, given the crucial role of GABA in 
numerous developmental processes (Kilb, 2012; Kilb et al., 2013; Ben-Ari, 2002). 
Additionally, down-regulation of GABAA receptors can also negatively impair dendrite 
formation (Kilb et al., 2013). In summary, these data suggest that a derangement in the 
developing GABAergic system is likely contributing to the abnormal cortical 
interneuronal circuitry in autism. Interestingly, it has been demonstrated that prenatal 
exposure to VPA, in rodents, also perturbs GABAergic transmission during early 
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developmental stages. Classically, VPA exerts its pharmacological effects by increasing 
brain concentrations of GABA (Mychasiuk et al., 2012). Because VPA is readily 
transported across the placenta (Alsdorf & Wyszynski, 2005; Kaneko et al., 1983), this 
appears to also be the case among rat offspring prenatally exposed to VPA (Mesdjian et 
al., 1982; Miyazaki, Matsuyama, Ichikawa, & Goto, 1988; Laeng et al., 2004; Manent et 
al., 2007). Based on these findings, we speculate that these elevated levels of GABA may 
result in attenuated GABAergic transmission at later stages in development (Schneider et 
al., 2007) via down-regulation of GABAA receptors and receptor binding. In fact, reduced 
GABAergic inhibition in the temporal cortex has been demonstrated (Banerjee et al., 
2013; Chomiak et al., 2013), giving rise to the possibility of a compromised GABAergic 
system in VPA animals. As a result, in the current study, we hypothesize that the changes 
in neuronal morphology/circuitry among our VPA animals may be attributed to 
disturbances in E/I neurotransmission and, consequently, result in altered development of 
GABAergic neuronal populations, similar to human cases of autism. Taking into account 
the suggested decrease in GABAergic tone in VPA animals, TS during the postnatal 
period may attenuate such effects, given its profound impact on the forebrain GABAergic 
system (Caldji, Diorio, & Meaney, 2000). Meaney and colleagues have demonstrated 
significantly higher levels of GABAA receptor binding in adult offspring of high 
licking/grooming mothers, suggesting that early TS treatment does, indeed, produce 
lifelong alterations in the GABAA receptor complex of animals (Francis & Meaney, 
1999; Kaffman & Meaney, 2007; Caldji et al., 2000). Additionally, significant increases 
in the expression of enzymes that synthesize GABA in the mPFC were also exhibited 
among adult offspring, following early postnatal TS (Caldji et al., 2000). Because 
 
 
 
 
84 
prenatal exposure to VPA may result in down-regulation of GABAA receptor binding and 
reduction in protein levels of GABA-synthesizing enzymes, it seems plausible that early 
TS treatment may be reversing such effects. In fact, early TS may be preventing or 
interfering with the cellular sequelae of events following prenatal VPA exposure, 
resulting in ‘normalized’ brain circuitry. While a plethora of literature supports a 
disturbed or suppressed GABAergic system in the autistic brain, it appears that early TS 
treatment allows for increased GABAergic inhibition, potentially countering not only the 
E/I imbalance, but also the consequent neuroanatomical effects following VPA insult. 
Although the proposed cascade of cellular events during development is highly 
speculative, it is obvious that a plastic interaction between prenatal VPA exposure and 
early TS treatment is occurring.  
One difficulty with the GABA-related changes in E/I balance is that the increase 
in excitation might be expected to increase excitatory synapses. The decrease in spine 
density, and thus the likely decrease in excitatory synapses, in the current study thus 
would appear to be at odds with at least one prediction of the E/I imbalance hypothesis. 
The difficulty is that given that GABA has an excitatory role in the developing brain as 
well as an inhibitory role the mature brain, our seemingly paradoxical spine density 
results could reflect changes in the E/I balance during development and during different 
critical periods, with less predictable consequences on cerebral morphology, possibly 
related to epigenetic effects that influence synaptic organization. This remains to be seen.   
Another explanation underlying the plastic interaction between prenatal VPA 
exposure and early TS treatment may be related to the endogenous expression of 
fibroblast growth factor-2 (FGF-2) – a potent neurotrophic growth factor – during this 
 
 
 
 
85 
critical period. Gibb et al. (Gibb & Kolb, submitted for publication) have reported that 
early TS treatment leads to increased FGF-2 expression in both the skin and brain. Given 
that FGF-2 is a key facilitator of recovery following early cortical injury (Gibb et al., 
2010; Comeau, Hastings, & Kolb, 2007; Gibb & Kolb, submitted for publication), we 
speculate that increased expression of FGF-2 in response to early TS would likely 
contribute to alterations in cortical plasticity in our VPA animals. It is plausible that the 
consequential increases of FGF-2 following TS during the postnatal period is, indeed, 
altering the neuroanatomical sequelae in the VPA brain, producing long-lasting changes. 
Further studies are warranted to elucidate the proposed relationship between E/I 
neurotransmission, GABAergic signaling, neurotrophic growth factors, and neuronal 
circuitry in VPA rats, which may lay a basis for understanding the therapeutic effects of 
TS treatment in this model, as well as in human autism studies of infant massage.  
  
3.5.4. Conclusion 
Analogous to infant massage or touch therapy, several reports have suggested the 
effectiveness of TS treatment in attenuating core autistic behaviors and touch aversion in 
autistic patients (Fields et al., 1997; Escalona et al., 2001; Cullen, Barlow, & Cushway, 
2005a, b). It has been speculated that TS enhances parasympathetic (vagal) activity in 
autistic patients, suggesting that a physiological change is taking place following the 
experience (Field, 1998). While this may be the case, no detailed mechanism has been 
established, especially in terms of brain plasticity. To date, the current study is the first of 
its kind to examine the neuroanatomical correlates of early TS treatment in a rodent 
model of autism. Despite the lack of remediation or improvement in behavior among our 
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VPA animals, we offer insight into the powerful remediating abilities of early TS 
treatment on brain anatomy in the regions measured here. Understanding the underlying 
mechanisms that restore plasticity in affected neuronal circuits may be the first step to 
better identify the neuroanatomical changes that mediate these effects in the autistic 
brain. This may yield wider implications not only for further development of therapeutic 
interventions that enhance brain activity and behavior in animal models of autism, but 
also for the application of such therapies to attenuate autistic symptoms in humans. 
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CHAPTER 4 
 
General Discussion 
 
This thesis contributes to the large literature investigating the utility of maternal 
challenge with VPA as an animal model of ASD. Although clinical relevance of the VPA 
rodent model has been documented extensively (Rodier et al., 1997b; Roullet et al., 
2013), further examination of the association between behavioral and neurobiological 
profiles would confirm the face, construct, and predictive validity of this model in 
simulating human ASD. That is, analysis of the ethological, etiological, and therapeutic 
similarities to human ASD would provide proof-of-principle for the VPA rodent model. 
As such, the objective of this thesis was to examine the perturbations in the 
neurodevelopmental trajectories – during juvenile and adulthood – as a consequence of in 
utero VPA exposure. The synergistic interaction between brain and behavior was 
considered and compared to facets of human ASD, to evaluate the utility of the VPA 
rodent model. Furthermore, the predictive validity of the VPA rodent model was also 
assessed by examining the therapeutic effects of early TS in rats prenatally exposed to 
VPA, on both behavioral and neuroanatomical levels. The results of these studies 
produced a number of findings that offer insight into the behavioral and neural 
underpinnings of ASD, as well as shed light on the validity and limitations of the VPA 
rodent model. The findings are summarized below.  
 
4.1. Translational Value of the VPA Rat Model of ASD 
Developing an animal model for ASD poses a challenge for researchers, as the 
etiological basis of the disorder remains to be determined. However, environmentally 
 
 
 
 
88 
induced rodent models have appeared to provide a unique avenue to explore the possible 
mechanisms underlying ASD. More specifically, the VPA rat model of ASD has 
undergone rigorous behavioral and neuropathological evaluation, providing a strong basis 
for the relevance of this model to human ASD. The studies presented in the current thesis 
further contribute to this large body of rodent research, supporting the conclusion that in 
utero exposure to VPA produces a viable and translational model for the study of ASD, 
as many of the behavioral and neuroanatomical findings appear to be consistent with 
human literature. A summary of the observed behavioral changes is presented in table 
4.1.  
As described in the DSM-V, qualitative impairments in social interaction and 
communication constitute two of the core clinical features of ASD. Failure to develop 
and maintain peer relationships, lack of social reciprocity and theory of mind, a paucity 
of nonverbal communication, and reduced eye contact all encompass various aspects of 
impaired social functioning in ASD (Adrien et al., 1991; Jordan, 2003; Seltzer et al., 
2003; American Psychiatric Association, 2013; Ventola et al., 2013). Although 
comparison of sociality in ASD patients and rodents is not directly feasible, interesting 
parallels can be drawn to evaluate the validity of the VPA model in simulating impaired 
social functioning characteristic of human ASD (chapter 2). For instance, in our paradigm 
of social play, VPA rats were less likely to engage in defensive tactics that promote 
bodily contact and reciprocal exchanges, thereby implying a refusal of body contact and 
an inability to facilitate social interactions, both of which have been reported in the 
human ASD literature (Adrien et al., 1991; Gillberg et al., 1996). Furthermore, a 
reduction in the rate of USV calling per bout of play fighting – that is, discordance 
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between vocalizing during playful interactions – suggest that aspects of being able to 
communicate effectively while engaging in dynamic social interactions have been 
disrupted or altered as a consequence of in utero VPA exposure. Dysregulation of socio-
communicative abilities and/or social pragmatics may be driving such changes, as 
exhibited in clinical ASD populations (Baron-Cohen, 1988). Furthermore, ASD patients 
also present with several comorbid symptoms, some of which parallel the behavioral 
impairments observed in the present studies. Executive function difficulties were 
observed in the non-match-to-sample T-maze task, where VPA animals took significantly 
longer to reach criterion than controls (chapter 3). It is plausible that VPA animals 
imparted a greater number of perseverative responses or possessed difficulties in problem 
solving, both of which are characteristic of cognitive impairment in ASD (McEvoy et al., 
1993; Mychasiuk et al., 2012). In the Whishaw tray reaching task, female VPA animals 
exhibited a reduction in the percent hits – defined as the total number of successful 
reaches over the total number of attempts – implying motor skill dysfunction, once again 
paralleling the reported delay in motor skill development in clinical ASD populations 
(chapter 3; Papadopoulos et al., 2011; Mychasiuk et al., 2012).  
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Table 4.1. Summary of findings for juvenile (A) and adult behavior (B-E) in VPA rats 
	  	   Prenatal VPA 
	  	   Male Female 
A. Play 
	  
	  	  
           Attacks n/a -­‐	  
           Defence n/a -­‐	  
           Pins n/a -­‐	  
           Complete Rotation n/a ê 
           Partial Rotation n/a -­‐	  
           Evasion n/a -­‐	  
           Other n/a é 
           Mounting n/a é 
           Body Shakes n/a é 
           Scratching n/a - 
           Stereotyped Grooming n/a - 
           Rate of USVs n/a ê 
  
  
B. T-Maze 
	  
	  	  
           Days to Criterion é é+ 
  
  
C. Whishaw Tray Reaching 
	  
	  	  
           % Hits -­‐	   ê 
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D. Locomotor Activity é é+ 
  
  
E. EPM 
	  
	  	  
           Time in Closed Arms -­‐	   ê 
           Time in Open Arms -­‐	   -­‐	  
+, Trend towards significance or significant interaction 
  
At the neuroanatomical level, significant reductions in dendritic branching, 
complexity, and spine density were exhibited in the mPFC and OFC in rats prenatally 
exposed to VPA (chapter 3). Although abnormal assembly of synapses and dendritic 
spines has been reported in the pathogenesis of ASD (Watts, 2008), the type and location 
of such alterations vary with age and from case to case. Moreover, a thorough 
examination of the dendritic morphology in the mPFC and OFC of ASD patients has not 
yet, to our knowledge, been quantified, but evidence of frontal lobe cellular abnormalities 
and behavioral deficits suggest that the PFC circuitry is likely implicated (Prior & 
Hoffman, 1990; Carper & Courchesne, 2005). Reports of mild disruptions of laminar 
organization (Bailey et al., 1998), reduced spine density (Williams, Hauser, Purpura, 
DeLong, & Swisher, 1980), and patches of decreased pyramidal cell density (Belichenko, 
Hagberg, & Dahlstrom, 1997) in the frontal lobes of ASD patients have been 
demonstrated, lending to the idea that alterations in the dendritic organization of the PFC 
are likely to emerge.  
 
4.2. Face and Construct Validity of the VPA Rat Model of ASD 
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 ASD is a behaviorally defined disorder characterized principally by social-
communicative deficits, and restrictive and repetitive behaviors and/or interests 
(American Psychiatric Association, 2013). With the emergence of symptoms in early 
childhood, the diagnosis of ASD is solely based on behavioral assessment, thus, 
highlighting the importance of comparable behavioral endpoints in potential animal 
models of ASD. Validation of rodent models of ASD, therefore, lies primarily in the 
phenomenological similarity between the behavioral features exhibited in the animal 
model to those observed in human ASD (face validity) and, the accuracy by which the 
animal model mimics the etiopathogenic mechanisms involved in the pathogenesis of the 
human disorder (construct validity) (Belzung, Leman, Vourc’h, & Andres, 2005; 
Tordjman et al., 2006). The evidence from this thesis corroborates previously published 
work suggesting that the VPA rat model of ASD is, indeed, a viable tool and relevant 
model of ASD. Namely, the VPA model of ASD exhibits significant face and construct 
validity, suggesting that the observed behaviors in the rodents are etiologically and 
ethologically relevant and comparable to human ASD (Patterson, 2011; Schneider & 
Przewlocki; 2011; Chomiak et al., 2013; Roullet et al., 2013). 
 With respect to the principle of face validity, reproduction of core ASD 
symptomology constitutes the primary criterion in validating the VPA rat model. 
Qualitative impairments in social interaction and social communication were exhibited 
among VPA juvenile rats during rough-and-tumble play – as outlined in chapter 2 – 
implying impaired sociality as a consequence of in utero VPA exposure. More 
specifically, disrupted facilitation of dynamic social interactions, marked by reductions in 
contact-promoting maneuvers and rate of USVs emitted per bout of play fighting, were 
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thought to reflect ambivalence in social relations, dysregulation of pragmatics, deficits in 
turn taking, and altered socio-communicative function – all of which are characteristic of 
impaired social functioning in ASD (Baron-Cohen, 1988; Adrien et al., 1991; Jordan, 
2003; Seltzer et al., 2003; American Psychiatric Association, 2013). Furthermore, an 
extensive body of rodent literature investigating the effects of in utero VPA exposure on 
social and communicative abilities using alternate behavioral paradigms and assays, has 
consistently replicated and confirmed the findings of impaired sociality and 
communication (Schneider & Przewlocki, 2005; Markram et al., 2008; Chomiak et al., 
2010; Gandal et al., 2010; Kataoka et al., 2013; Kim et al., 2011), further validating the 
ethological relevance of the VPA model to the human correlate. With respect to repetitive 
stereotypical patterns of behavior – another domain of core ASD symptomology – studies 
in the current thesis were unable to delineate and characterize such impairments among 
prenatally exposed VPA animals in the behavioral paradigms employed. Although 
impaired motor performance in VPA females was revealed on the Whishaw tray reaching 
task (chapter 3), it is unclear whether this impairment reflects motor stereotypies or an 
inability to execute reaching abilities. That is, a motor stereotypy may be expressed as 
rapid multiple reaches towards the food, whereas a failure to execute reaches may be 
expressed as uncoordinated movements. Interestingly, however, despite the absence of 
sensitive behavioral measures of repetitive/stereotyped patterns of behavior in the present 
thesis, several independent laboratories have concluded face validity related to this core 
symptom. That is, increased patterns of repetitive/stereotyped movements, measured on a 
variety of behavioral paradigms, has been shown in rodents prenatally exposed to VPA 
(Schneider & Przewlocki, 2005, Schneider et al., 2008; Markram et al., 2008; Gandal et 
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al., 2010; Mehta, Gandal, & Siegel, 2011). Even more, as postulated by Tordjman and 
collegues (2006), the greater number of features represented by the VPA model, the more 
viable and pertinent animal model of ASD it will be. As such, additional comorbid 
behavioral deficits, unrelated to core symptomology but consistent with human ASD, 
were exhibited in the present studies, including altered anxiety-like behaviors, 
hyperactivity, reduced cognitive function, and sexual behavior – further exemplifying the 
VPA rodent model as a multi-trait approach to better understand the clinicopathology of 
ASD. Thus, corroborated with the ever-growing avenue of VPA rodent research, the 
behavioral studies in this thesis confirm that the VPA rodent model of ASD demonstrates 
significant face validity, whereby the observed rodent behaviors are ethologically 
pertinent to the behavioral deficits in clinical ASD populations. 
 Despite being elusive in nature, ASD is a multifactorial disorder that is variable in 
the expressed phenotype. In spite of the heterogeneous etiology – genetic and/or 
environmentally induced – when evaluating pertinent animal models of ASD, 
demonstration of construct validity is another necessary and important component. That 
is, the accuracy by which the animal model replicates the underlying causes of the 
disease (Belzung et al., 2005; Schneider & Przewlocki, 2005). With respect to the VPA 
rodent model of ASD, translation of human epidemiological data informed the creation of 
this model, whereby in utero exposure to VPA during the first trimester of pregnancy 
increases the incidence of ASD and intellectual disability (Christianson et al., 1994; 
Moore et al., 2000; Rasalam et al., 2005; Christensen et al., 2013). On the basis of 
etiological relevance to human ASD, the VPA model does demonstrate construct validity 
to ASD. Moreover, of the vast number of animal models that adopt a multifactorial 
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approach to the study of ASD, the VPA model exhibits behavioral, genetic, 
immunological, biochemical, neuroanatomical, and cellular similarities to human ASD 
(for review, see Schneider & Przewlocki, 2005), further validating the viability of this 
model. Although general consensus has been met regarding the construct validity of the 
VPA rodent model (Patterson, 2011; Roullet et al., 2013), it is important to keep in mind 
that this model represents a proportion of individuals with ASD; that is, those exposed to 
VPA in utero. Although aspects of the VPA rodent model may be translational to other 
populations of ASD, it does not entirely mimic the etiology of children unexposed to 
VPA.  
 
4.3. Predictive Validity of the VPA Rat Model of ASD: Implications for 
Remediation 
In reference to psychopathological animal models, the principle of predictive 
validity refers to the model’s ability to make precise predictions about the disorder in 
question. That is, in a more narrow sense, the ability of an animal model to predict and 
produce treatments of therapeutic value in both animals and humans similarly (Belzung et 
al., 2005; Schneider & Przewlocki, 2005; Tordjman et al., 2006). In addition to face and 
construct validity, predictive validity constitutes an important component in the 
validation of animal models of ASD. 
This thesis examined the therapeutic effects of early TS treatment in attenuating 
the behavioral and neuroanatomical aberrations in rats prenatally exposed to VPA 
(chapter 3). Given the known benefits of touch therapy – an intervention equivalent to TS 
in animals – in promoting neurobehavioral development and improving core 
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symptomology in pediatric ASD populations (Field et al., 1997; Escalona et al., 2001; 
Cullen et al., 2005b; Jones & Mize, 2007), studies in the present thesis sought to evaluate 
the beneficial effects of early TS on the behavioral expression and neuropathological 
deficits in animals prenatally exposed to VPA. Remediation or reversal of the VPA-
induced changes in behavior and neuroanatomy would confirm the predictive validity of 
the VPA model, under the assumption of comparable therapeutic efficacy in both humans 
and animal models. While the therapeutic effects of early TS treatment were detected in 
the neuroanatomical pathology of rats prenatally exposed to VPA, completely reversing 
the VPA-induced alterations in dendritic organization in the mPFC and OFC, this was not 
the case behaviorally. That is, contrary to expectation, early TS failed to remediate or 
alter behavior in all rats, VPA or control. Given the conflicting behavioral and 
neuroanatomical findings, one might suggest that the predictive validity of the VPA 
model is questionable. That is, if an animal model is considered predictive based on its 
ability to characterize a therapeutic treatment for human ASD (Tordjman et al., 2006), it 
is plausible that the VPA model is predictive but only to an extent. However, based on 
the significant alterations in the PFC (post-TS) in our rodent study, and the numerous 
reports of improvements in core symptomology following touch therapy in children with 
ASD (Field et al., 1997; Escalona et al., 2001; Cullen et al., 2005a; Jones & Mize, 2007), 
we have reason to believe that the VPA model does, indeed, exhibit predictive validity. 
The lack of TS-induced modification to behavior among all animals may rather be 
attributed to the behavioral measures employed. More specifically, it is likely that the 
behavioral tasks utilized were not sensitive enough to detect the subtle effects of TS 
treatment. This proposition is further confirmed by Richards and colleagues (2012), 
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where TS treatment failed to be detected on a range of behavioral tasks identical to the 
ones utilized in this thesis. At the very least, we propose that TS is a potent avenue for 
intervention, given the pronounced therapeutic effects on neuroanatomy (and quite 
possibly behaviorally as well, in the case that more detailed behavioral tasks are 
employed instead) in the VPA rat model of ASD. This leads us to confirm, at least in 
part, the predictive validity of the VPA model, given the capacity of this model to 
validate behavioral interventions with relevance to human ASD. 
 
4.4. Limitations and Future Directions 
While the present thesis assessed the validity of the VPA rat model in simulating 
the neurodevelopmental disturbances as seen in human ASD, numerous future 
experiments could be conducted to remedy the limitations present in the current studies, 
as well as address novel questions of interest. One limitation to the study of sociality in 
rats prenatally exposed to VPA is the absence of male subjects. Given the confirmed 
male bias in ASD – a 4 to 1 male/female ratio (Rubenstein, & Merzenich, 2003; Currenti, 
2010) – examination of the playful interactions and associated USVs in VPA-treated 
juvenile male rats may shed light on the sex-specific phenotypes seen in human ASD. 
Furthermore, comparison of the playful dynamics of VPA male and female subjects 
would further evaluate the hypothesis of masculinized-typical play in females, as 
postulated by the ‘extreme male brain’ theory (Baron-Cohen, 2002; Knickmeyer, 
Wheelwright, & Baron-Cohen, 2008). Given the VPA-induced changes in the dynamics 
of play and communication occurring therein during the juvenile period, it would also be 
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interesting to assess whether these alterations in sociality propagate into adulthood (as 
exhibited in human cases of ASD). 
One of the most significant limitations in this thesis was the inability to detect the 
therapeutic effects of early TS on a multitude of behavioral tasks. That is, although TS 
treatment appeared to significantly alter (and remediate, in the case of VPA animals) the 
neuronal morphology in the PFC, no significant differences were observed on the 
behavioral tasks employed. As previously suggested (chapter 4.3), it is likely that the 
behavioral protocols utilized were not sensitive to the subtle effects of TS and, thus, more 
thorough tests are required for future experiments. Detailed behavioral paradigms, such 
as social play fighting, skilled reaching, or even measurement of 50-kHz and 22-kHz 
USVs may prove to better highlight the therapeutic effects of TS in both VPA and control 
animals. 
While the current studies assessed behavior in the juvenile and adult periods, it 
would have been interesting to implement behavioral testing in the early, preweaning 
period. Seeing as how manifestation of atypical behaviors and subsequent diagnosis of 
ASD typical occurs around the age of three (Chawarska et al., 2014), behavioral testing 
of rats during preweaning period may allow for the identification of early sensory-motor, 
social-emotional, and communicative impairments predictive of ASD. Furthermore, by 
assessing the earliest manifestations of atypical behavioral development, targeted 
interventions during these critical periods could be adopted to counter the abnormal 
developmental cascade that eventually leads to full-blown ASD. Additionally, anatomical 
and epigenetic analysis during the preweaning, juvenile, and adult periods could be also 
assessed to examine the synergistic relationship between brain and behavior, and if these 
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changes are persistent lifelong. Owing to the fact that interplay of genetic, epigenetic, and 
environmental processes are suspected to be involved in the pathogenesis of ASD 
(Schneider & Przewlocki, 2011), significant changes in DNA methylation and the 
epigenetic processes regulating cellular development would be predicted.  
Finally, in the future, it would be valuable to adapt the VPA rat model of ASD to 
better reflect the human clinic. That is, examination of the effects of long-term fetal VPA 
exposure, at clinically relevant doses, on the functional and anatomical outcomes of 
offspring would be of interest. Given the seemingly high degree of ecological validity 
associated with this paradigm of maternal epilepsy, one would predict that prenatal 
exposure to small daily dosages of VPA, throughout gestation and during the lactation 
period, will produce behavioral and neuropathological characteristics equivalent to those 
observed in human ASD, as well as simulate a greater translational model of autism than 
the previous acute high dosage paradigm. 
 
4.5. Conclusion 
VPA maternal challenge in rodents has long been proposed as a viable animal 
model to study ASD. The present thesis examined the utility of the VPA rodent model of 
ASD by assessing the behavioral and neurodevelopmental trajectories in rats prenatally 
exposed to VPA, as well as the therapeutic effects of an enriching environmental 
manipulation on behavioral expression and pathology. Corroborated with the large VPA 
rodent literature, we conclude that the VPA model exhibits all elements of a translational 
animal model, namely, face, construct, and predictive validity, given the striking 
behavioral and neuropathological similarities to human ASD profiles. Nonetheless, 
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evidence from this thesis further illustrates how environmental challenges can play a 
significant role in the etiology of ASD, producing persistent changes in the structure and 
functioning of the developing brain.  
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